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Abstract  
The aim of this PhD thesis is the realization of an in vitro human skin 
model and its validation as platform for testing bioactive molecules. Due 
to its endogenous nature  the human skin equivalent realized was able to 
recapitulate both physiological and pathological status of the human skin. 
As consequence it has been used for recapitulating the typical UVA-
induced skin alterations and to test the efficacy of photoprotectants. The 
thesis has been organized as follow: chapter 1 deals with a critical 
analysis of the literature reporting an overview of the existing human skin 
equivalent model highlighting their importance as alternative to animal 
model for testing the irritancy and toxicity of several bioactive 
compounds. This is a very important point, since the EU Directive 
prohibits the use of animals in cosmetic testing for certain endpoints, and 
in general strongly dictate the reduction of animal testing. 
In the chapter 2 the realization of 3D dermis equivalent completely made 
up of endogenous extracellular matrix has been reported. The dermis is 
the connective part of the skin, we realized it by assembling functional 
microtissues precursor and demonstrate the presence of all dermis 
matrix components by histological and immunohistochemical analyses. 
In the chapter 3 the 3D human dermis equivalent model has been used 
to quantify photoaging damage induced by UVA irradation to cells and 
extra-cellular matrix (ECM) and to evaluate bioactivity of cosmetic 
compounds. To this aim, matrix metalloproteinases (MMPs), collagen 
and hyaluronic acid (HA) synthesis -as well as collagen organization 
remodeling- have been investigated by immunofluorescence, histological 
and second harmonic generation (SHG) imaging. The results indicate 
that, despite to the existing model consisting in fibroblasts-populated 
exogenous matrix, the endogenous dermal equivalent developed is a 
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unique model to investigate and quantify in vitro, the alterations in the 
structure and assembly of the ECM due to photoaging. 
In chapter 4 is reported the bio-fabrication of a skin full thickness in vitro 
model. After a first morphological characterization, through histological 
and immunofluorescence analysis, the model has been used as in vitro 
screening tool. A photodamage due to UVA has been induced as 
reported in the chapter 4, and the damage on both dermal and epidermal 
part of the skin has been assessed. Finally the effect of a cosmetic 
compound has been tested. Our results reported that the model is able to 
recapitulate several events typical of in vivo photoaging (collagen 
reduction, MMP overexpression and cellular damage such as reduction 
of Ki67 and P63 expression).  We speculated that due to its endogenous 
nature the skin model realized is able to recapitulate a more physiological 
microenviroment for cell and tissue development compared to existing 
fibroblasts-populated exogenous matrix.  
Moreover we hypothesized that the human skin model realized could be 
used not only in vitro but also in vivo as skin substitute in clinical 
application. 
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Chapter 1 
In vitro skin models as a testing platform: an 
overview 
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Introduction 
Skin is the largest organ of human body and is responsible for the 
protecting the body from the environment. However, when this barrier is 
disrupted, as in the case of large wounds, burns, and chronic, diabetic 
ulcers, the clinical use of grafted skin has shown therapeutic efficacy. 
However, such skin autografts are limited by healthy donor site 
availability. As a result, many approaches have been explored for skin 
replacement therapy, including cadaver skin. While these options offer 
temporary benefit, they only persist at the grafting site for a limited 
amount of time. In response to these limitations, new approaches for skin 
engineering have been tested and developed in last years.  
These advances have led to the development of in vitro models to study 
wound healing, skin cancer, and skin biology. Since skin barrier function 
is recapitulated in these in vitro skin equivalents, they are now an 
important part of consumer product testing. For example, since the 
European Union will no longer allow the sale of new consumer products 
tested on animals, it is essential that Companies developing consumer 
products who wish to sell them abroad must find alternative modes of 
testing that avoids the use of animals. In order to replace animal testing, 
engineered skin needs to closely mimic the complexity of the in vivo 
tissue and must respond to toxic and no toxic agents in a fashion that 
mimics native skin [1]. 
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Skin: structure and function 
The human skin is the largest organ of the body, making up 16% of body  
weight, with a surface area of 1.8m2. It has several functions, the most 
important being to form a physical barrier to the environment, allowing 
and limiting the inward and outward passage of water, electrolytes and 
various substances while providing protection against micro-organisms, 
ultraviolet radiation, toxic agents and mechanical insults (see Table 1). 
However, damaged skin cannot perform these critical functions and 
numerous complications how infection or fluid loss can occur.  
 
Table 1. Functions of the skin. 
 Provides a protective barrier against mechanical, 
thermal and physical injuryandnoxious agents. 
 Prevents loss of moisture. 
 Reduces the harmful e€ects of UV radiation. 
 Acts as a sensory organ. 
 Helps regulate temperature control. 
 Plays a role in immunological surveillance. 
 Synthesises vitamin D3 (cholecalciferol). 
 Has cosmetic, social and sexual associations. 
  
Starting from the surface and reaching deep into the human skin consists 
by an epithelium, the epidermis; by a connective tissue, dermis and by an 
adipose tissue called subcutaneous (fig.1). 
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Figure 1  : Scheme of different layers of the human skin [2]. 
 
Epidermis 
The epidermis is the outer layer, serving as the physical and chemical 
barrier between the interior body and exterior environment, maintaining 
physiological homeostasis [3]. 
The epidermis is stratifed squamous epithelium. The main cells of the 
epidermis are the keratinocytes, which synthesise the protein keratin. 
Protein bridges called desmosomes connect the keratinocytes, which are 
in a constant state of transition from the deeper layers to the superfcial. 
The four separate layers of the epidermis are formed by the differing 
stages of keratin maturation [4]. The epidermis varies in thickness from 
0.05 mm on the eyelids to 0.8±1.5 mm on the soles of the feet and palms 
of the hand. Moving from the lower layers upwards to the surface, the 
four layers of the epidermis are (fig.2): 
_ stratum basale (basal or germinativum cell layer) 
_ stratum spinosum (spinous or prickle cell layer) 
_ stratum granulosum (granular cell layer) 
_ stratum corneum (horny layer). 
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In addition, the stratum lucidum is a thin layer of translucent cells seen in 
thick epidermis. It represents a transition from the stratum granulosum 
and stratum corneum and is not usually seen in thin epidermis. Together, 
the stratum spinosum and stratum granulosum are sometimes referred to 
as the Malphigian layer. 
 
Figure 2. Layers of the epidermis. 
Stratum basale 
The innermost layer of the epidermis which lies adjacent to the dermis 
comprises mainly dividing and non-dividing keratinocytes, which are 
attached to the basement membrane by hemidesmosomes. As 
keratinocytes divide and differentiate, they move from this deeper layer to 
the surface. Making up a small proportion of the basal cell population is 
the pigment (melanin) producing melanocytes. These cells are 
characterised by dendritric processes, which stretch between relatively 
large numbers of neighbouring keratinocytes. Melanin accumulates in 
melanosomes that are transferred to the adjacent keratinocytes where 
they remain as granules. Melanin pigment provides protection against 
ultraviolet (UV) radiation; chronic exposure to light increases the ratio of 
Chapter 1 
 
- 8 - 
 
melanocytes to keratinocytes, so more are found in facial skin compared 
to the lower back and a greater number on the outer arm compared to 
the inner arm. 
The number of melanocytes is the same in equivalent body sites in white 
and black skin but the distribution and rate of production of melanin is 
different. 
Intrinsic ageing diminishes the melanocyte population. 
Merkel cells are also found in the basal layer with large numbers in 
touchsensitive sites such as the fingertips and lips. They are closely 
associated with cutaneous nerves and seem to be involved in light touch 
sensation. 
Stratum spinosum 
As basal cells reproduce and mature, they move towards the outer layer 
of skin, initially forming the stratum spinosum. Intercellular bridges, the 
desmosomes, which appear as `prickles' at a microscopic level, connect 
the cells. Langerhans cells are dendritic, immunologically active cells 
derived from the bone marrow, and are found on all epidermal surfaces 
but are mainly located in the middle of this layer. They play a significant 
role in immune reactions of the skin, acting as antigen-presenting cells. 
Stratum granulosum 
Continuing their transition to the surface the cells continue to flatten, lose 
their nuclei and their cytoplasm appears granular at this level. 
Stratum corneum 
The final outcome of keratinocyte maturation is found in the stratum 
corneum, which is made up of layers of hexagonal-shaped, non-viable 
cornified cells known as corneocytes. In most areas of the skin, there are 
10±30 layers of stacked corneocytes with the palms and soles having the 
most. Each corneocyte is surrounded by a protein envelope and is filled 
with water-retaining keratin proteins. The cellular shape and orientation 
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of the keratin proteins add strength to the stratum corneum. Surrounding 
the cells in the extracellular space are stacked layers of lipid bilayers. 
The resulting structure provides the natural physical and water-retaining 
barrier of the skin. The corneocyte layer can absorb three times its 
weight in water but if its water content drops below 10% it no longer 
remains pliable and cracks. The movement of epidermal cells to this 
layer usually takes about 28 days and is known as the epidermal transit 
time. 
Dermoepidermal junction/basement membrane 
This is a complex structure composed of two layers.  The structure is 
highly irregular, with dermal papillae from the papillary dermis projecting 
perpendicular to the skin surface. It is via diffusion at this junction that the 
epidermis obtains nutrients and disposes of waste. The dermoepidermal 
junction flattens during ageing which accounts in part for some of the 
visual signs of ageing. 
Dermis 
Under the epidermis, connected to it by the dermal-epidermal junction, is 
localized the dermis, a dermal connective tissue which contains 
extracellular matrix proteins such as collagen, primarily collagen of type I 
and in lesser amounts of type III, elastic fibers, fibronectin, laminin and 
proteoglycans which are produced and secreted into the extracellular 
matrix by fibroblasts, the primary cell type of the dermis [5]. 
The dermis varies in thickness, ranging from 0.6 mm on the eyelids to 3 
mm on the back, palms and soles. It is found below the epidermis and is 
composed of a tough, supportive cell matrix. Two layers comprise the 
dermis: 
_ a thin papillary layer 
_ a thicker reticular layer. 
The papillary dermis lies below and connects with the epidermis. It 
contains thin loosely arranged collagen fibres. Thicker bundles of 
Chapter 1 
 
- 10 - 
 
collagen run parallel to the skin surface in the deeper reticular layer, 
which extends from the base of the papillary layer to the subcutis tissue. 
Collagen fibres make up 70% of the dermis, giving it strength and 
toughness. Collagen is the most abundant protein in dermal connective 
tissue and is mainly seen as structural protein. Collagens consist of three 
polypeptide chains. These are super-coiled around a central axis in a 
right-handed manner to form a triple helix. Collagen molecules self-
assemble into collagen fibers, which form collagen bundles after cross-
linking [6]. During the biosynthesis of collagen, the molecule undergoes 
several post-translational modifications. Depending on their structure and 
supra-molecular organization, collagens can be classified into fibrillar 
(accounting for 90% of all collagens) and non-fibrillar collagens. For 
example, fibrillar collagens are responsible for conferring tension and 
provide support and structural integrity of the skin [7, 8]. In contrast, 
basement membrane collagens such as collagen type IV are more 
flexible, giving the basement membrane its typical characteristics.  
Elastin is a fibrous protein, hard and stable responsible of the elastic 
properties of connective tissue Elastic fibers have a central core of 
amorphous, hydrophobic cross-linked, elastin surrounded by a tubular 
shell fibrillary proteins. Elastic fibers are a minor component and play a 
functional role in resisting deformational forces and providing the skin’s 
elasticity by forming a fine network [5]. In short, collagen and elastin may 
be considered as the bricks of extra-cellular matrix due to their 
contribution to the mechanical properties of  ECM. 
Proteoglycans are also non-collageneous proteins similar to elastic fibers 
and comprising only a small percentage of skin and provide viscosity and 
hydration. They are responsible for the assembly of the extracellular 
matrix and regulates the diameter and structure of collagen fibrils, thus 
preventing abnormal fibril assembly [9]. Two of the most common 
proteins responsible for cell adhesion are fibronectin and laminin. 
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Fibronectin is the second most abundant protein in ECM, where it is 
organized into a fibrillar network. It is a large glycoprotein dimer and each 
monomer contains three types of repeating units designated type I, II and 
III. In these units we can find functional domains responsible for 
interaction with cell surface receptors and with fibronectin itself. Laminin 
is a complex adhesion molecule especially found in the basement 
membrane of almost every tissue. These various extracellular matrix 
proteins in the dermal connective tissue mainly contribute to the 
maintenance of skin integrity and architecture. Therefore, damages to the 
dermal connective tissue by the aging process can be connected to 
structural changes of the skin as wrinkling, loss of elasticity, sagging and 
laxity.  
Tissue Engeenering of skin 
Tissue engineering is an interdisciplinary field of the regenerative 
medicine, focused on the creation of tissues and organs with biomaterials 
and nanostructures to   develop, sustain and repair an organ or tissue 
function. The main goal is to mimic the normal structure of a tissue. Cells 
and ECM are used to develop biological substitutes to be assimilated by 
the body during the tissue regeneration, and cells can also be used in a 
cell therapy procedure. To achieve these goals, an artificial (ECM) and a 
source of cells are required as well as growth factors (fig. 3 )[10]. Tissue 
engineered replacements play an important role in the treatment of skin 
wounds, but they are also an option for the treatment of several skin 
disorders affecting the patients’ general appearance and self-esteem; in 
these cases, skin substitutes and cell therapies may have important 
clinical applications. 
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Figure 3: Basic principles of Tissue Engeenering: Primary keratinocytes and 
fibroblasts are isolated from human donor tissues, which are then in vitro 
expanded prior seeding onto suitable scaffold materials/matrices. For a full-
thickness skin equivalent, the fibroblasts and the matrix are initially used to 
establish the dermal part. The keratinocytes are seeded afterwards on the top 
of the dermis to ultimately form the epidermal part of the skin substitute. The in 
vitro-engineered skin can serve as skin graft or can be used as human-cell 
based in vitro test system.[11] 
 
However, besides their use as in vivo grafts, recently, other applications 
have emerged for skin substitutes as in vitro test systems [12]. In this 
context, they enable not only the investigation of fundamental processes 
in the skin, but also the hazard assessment of various chemical or 
dermatological compounds that are topically applied on the skin without 
the need to use animal models. 
In fact,  the increased awareness of animal welfare within the general 
public and the scientific community has stimulated recent advances 
toward the development of commercial and noncommercial in vitro 
human skin equivalent (HSE) models. The need for alternative models to 
assess dermal toxicity is great in biomedical research to test or evaluate 
the toxicity of numerous compounds. Although these in vitro models may 
serve as alternatives, they cannot completely satisfy the physiological or 
anatomical requirements found in in vivo models. In order to reduce or 
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replace animals in scientific research, ‘‘animal alternatives’’ are being 
pursued. 
These HSE cell culture models have been used to study percutaneous 
absorption, metabolism [13] , and toxicology [14]. 
A number of pharmaceutical and cosmetic companies are using in vitro 
models to assure the safety of their products and to meet regulatory 
requirements to classify irritancy potential. In addition, these results are 
combined with other in vitro biochemical tests to determine the safety of 
the product. 
Today, in vitro reconstructed skin models are used globally in both 
industrial and academic research laboratories. In general terms, the 
implementation of these three-dimensional (3D) in vitro reconstructed 
human tissue models makes it possible for 
pharmaceutical, chemical and cosmetical product companies to: 
 test the efficacy of newly developed formulations and products 
and thus to use them for claim support, 
 reproducibly differentiate compounds that cause reversible and 
irreversible toxicity without resorting to in vivo animal testing, 
 provide accurate and measurable mechanistic information that 
can be utilized to determine whether a molecule or compound can 
be altered to reduce irritation or toxicity, without loss of efficacy, 
 objectively compare the toxicity and efficacy of newly developed 
compounds with those already in use in the market place for the 
same purpose, 
 reveal the precursor steps which lead to toxic reactions, thereby 
making reformulations possible, based on human response, 
 evaluate the long term stability or shelf-life of finished products or 
raw materials, 
 determine the potential health risks of employees exposed to 
chemicals (worker safety) [15]. 
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The importance of skin in vitro model: Cosmetics Directive 
and Regulation 
The cosmetic industry is complex. More than ever, manufacturers and 
distributors are facing new legislation. As innovative cosmetics as well as 
the technology behind them emerges and advances through new studies 
and research, so too does the demand for governance. But deciphering 
the demands of legislation can be challenging.  
In recent years national and European legislation has placed 
considerable constraints on industry to totally abandon animal-based test 
systems when assessing the toxicological potential of chemicals and 
finished products. Both the REACH directive (Registration, Evaluation, 
Authorization and Restriction of Chemicals), the Classification, Labeling 
and Packaging (CLP) directive and the EU Cosmetics directive demand 
for alternatives to animal testing. Hence they are creating a growing need 
for human reconstructed skin models, accelerating the adoption of these 
models in skin-related testing strategies required for regulatory purposes 
[16].  
In the  EU, regulations applied to cosmetic products are EU Cosmetic 
Directive (76/768/EEC) and the EU Cosmetic Regulation (EC 
1223/2009). 
 A Directive, by definition, is a legislative act that serves to direct, indicate 
or guide. A directive in the EU represents a guide that every member 
country has to transpose into its national legislation. However, because 
some countries are stricter than others about adoption of laws, 
sometimes rules are not equally applied everywhere as intended, 
resulting in the need to draft multiple versions of the directive specific to 
each country.  
A Regulation is a legislative act that imposes clear and detailed rules. A 
regulation is not required to be incorporated into the national laws, but is 
immediately enforceable in all member states. Keep in mind as well the 
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fact that a regulation only needs to be translated into the national 
language of the 27 EU member state. 
The EU Cosmetic Directive (76/768/EEC) was originally issued on July 
27, 1976 as an initial means of ensuring the safe sale [17] and 
distribution of cosmetic products within the EU Community market. With 
a primary goal of protecting overall consumer health, the Directive 
included rules on the composition [18],  labeling and packaging of 
cosmetic products. Thus, the responsibility for product safety lies with the 
cosmetic manufacturer or the legal person placing a cosmetic product on 
the Community market, who must be able to demonstrate that the 
product is safe for the consumer. But as the cosmetic industry advanced 
utilizing new, ground-breaking technologies and innovations, the 
legislation supporting it needed to change / evolve too. 
The Cosmetic Regulation 1223/2009 was adopted on the 30th of 
November 2009 to essentially replace the EU Cosmetic Directive. The 
regulation was created to implement a more robust approach at enforcing 
product safety and is immediately enforceable because there is no 
transposition into the laws of individual countries, and only translation 
into the languages of the EU member countries is required. 
The new EU Regulation 1223/2009 (Cosmetics Regulation) has been in 
force since 11 July 2013. It strengthens the safety of cosmetic products 
and streamlines the framework for all operators in the sector. The 
Regulation simplifies procedures to the extent that the internal market of 
cosmetic products is now a reality. 
The new Regulation replaces Directive 76/768/EC, and had been 
substantially revised on numerous occasions. It provides a robust, 
internationally recognised regime, which reinforces product safety while 
taking into consideration the latest technological developments, including 
the possible use of nanomaterials. The previous rules on the ban of 
animal testing were not modified. 
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The Cosmetics Directive provides the regulatory framework for the 
phasing out of animal testing for cosmetics purposes. 
Specifically, it establishes: 
 Testing ban – prohibition to test finished cosmetic products and cosmetic 
ingredients on animals; 
 Marketing ban – prohibition to market finished cosmetic products and 
ingredients in the EU which were tested on animals. 
The testing ban on finished cosmetic products applies since 11 
September 2004; the testing ban on ingredients or combination of 
ingredients applies since 11 March 2009. 
The marketing ban applies since 11 March 2009 for all human health 
effects with the exception of repeated-dose toxicity, reproductive toxicity, 
and toxicokinetics. For these specific health effects, the marketing ban 
applies since 11 March 2013, irrespective of the availability of alternative 
non-animal tests. 
The beginnings of Human Skin models  
One of first commercially available models was produced by 
Organogenesis, Canton, MA, USA and was called LSE (Living Skin 
Equivalent) and later Testskin I and II. This skin model was originally 
developed in 1991 [19, 20] and consisted of a differentiated epidermal 
tissue produced on a collagen lattice populated with human fibroblasts. 
Various test applications were developed using this skin construct 
including UV irradiation [21], skin irritation [22, 23], and dermal 
absorption [24]. 
At approximately the same time, another US based company called 
Advanced Tissue Sciences, La Jolla, CA, USA, launched a set of in vitro 
reconstructed human skin models under the brand name ‘Skin²TM. 
These full-thickness (dermis/epidermis) skin models called ‘Skin²TM 
ZK1300 and ZK1350 were shipped worldwide and evaluated thoroughly, 
both morphologically and biochemically [25, 26], and used in a wide 
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range of toxicological applications. These included skin corrosion for 
which regulatory approval was obtained by the US Department of 
Transportation (27), phototoxicity [28, 29, 30, 31], skin irritation [32, 33, 
34, 35] and dermal absorption [36, 37, 38, 3]. Unfortunately, despite the 
multiple successful validation efforts, the company’s shareholders 
decided to withdraw from the in vitro skin business in 1995 and focus 
entirely on the clinical skin equivalent called Dermagraft-TC, which was 
developed as a temporary wound cover for burn patients. 
Commercially available skin models today  
Today a variety of 3D in vitro reconstructed human skin model are 
commercially available on a routine basis. 
Some were already developed in the early 1990’s including the EpiSkin™ 
model (L’Oréal, Lyon, France) and EpiDerm™ model (MatTek 
Corporation, MA, USA). Subsequently, additional human skin models 
were introduced to the commercial market, including the RHE or 
Reconstructed Human Epidermis (SkinEthic, Lyon, France), the 
EST1000® skin model (CellSystems, Troisdorf, Germany), the Phenion® 
Full-Thickness Skin Model and OSREp (Open Source Reconstructed 
Epidermis) model (Henkel, Düsseldorf, Germany), the Straticell model 
(Straticell, Les Isnes, Belgium), the StrataTest® model (Stratatech, 
Madison, WI, USA) and the more recently introduced Labcyte model 
(Gamagori, Japan) and Vitrolife-Skin™ model (Kyoto, Japan). 
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The EpiSkinTM and SkinEthic RHETM skin models 
The EpiSkin™ (fig.4) model was originally developed by E. Tinois in 1991 
and is composed of a collagen lattice containing human fibroblasts, 
surfaced with a film of type IV collagen, overlaid with a fully differentiated 
human epidermis (40). 
The models were initially produced by the company Imedex (Lyon, 
France), that became acquired by L’Oréal in 1997. The SkinEthic RHE™ 
model was developed by M. Rosdy in 1990. This epidermal construct 
generated by seeding human keratinocytes on inert synthetic filters, 
which are consequently exposed to the air-liquid interface and 
maintained using a chemically defined culture medium (41). The model 
became commercially available in 1993 by SkinEthic Laboratories, which 
also was acquired by L’Oreal (in 2006). Today, both the EpiSkin™ and 
SkinEthic RHE™ (fig 4)(Reconstructed Human Epidermis)models are 
being produced by SkinEthic Laboratories, Lyon, France. 
    
Figure 4: Histological Hematoxylin-eosin staining of cross-section. (a) EpiSkin™ 
and (b) and SkinEthic RHE™ model. 
 
The EpiSkin™ and SkinEthic RHE™ models have been scientifically 
validated for skin corrosivity and skin irritation assessment by ECVAM 
[42, 43]. In addition, EpiSkin™ and SkinEthic RHE™ are also useful 
models for screening acute and chronic skin irritation of topical 
formulations [44], for testing the phototoxicity of raw materials or finished 
products [45, 46], for screening the genotoxicity potential of topically 
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applied compounds or formulations [47], for ranking the skin permeability 
and metabolism of products [48], for understanding the effects of UVA 
and UVB irradiation and UVB protection [49], dermal penetration [50] and 
for detecting the genomic and transcriptomic signatures [51], for contact 
allergy profiles [52]. 
The EpiDermTM and Epiderm-FTTM skin models 
The EpiDerm™ in vitro reconstructed skin model, produced by MatTek 
Corporation, Ashland, MA, USA was originally developed by J. Kubilus 
and M. Klausner. This model is also composed of human epidermal 
keratinocytes that develop a fully-differentiated epidermal tissue (fully 
differentiated natural epidermis displaying a basement membrane, 
proliferating keratinocytes and a stratum corneum) after air-liquid 
interface cultivation on inert polycarbonate membranes (fig. 5-a). The 
EpiDerm™ model was introduced to the commercial market in 1993 and 
was first described by Cannon et al, [53]. Later MatTek introduced a full-
thickness model called EpiDerm-FT™ that featured both epidermal and 
dermal layers (fig 5-b) [54]. 
 
Figure 5: Histological Hematoxylin-eosin staining of cross-section.  
(a) EpiDerm™  and (b) and EpiDerm-FT™ model. 
 
Shortly after, a melanocyte containing epidermal model called 
MelanoDerm™ [55] was developed. 
For 15 years, the company has consistently mass-produced, in a highly 
reproducible way, the EpiDerm™ tissues [56]. 
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The EpiDerm™ models are used by several industries in product 
development, claims substantiation, safety assessment and drug 
discovery and have been involved in several regulatory validation 
studies. These include skin corrosion [57, 58] and skin irritation [59,60] 
for which the model obtained regulatory approval as full replacement 
method, and are referenced in the OECD TG 431 (skin corrosion) and 
OECD TG 439 (skin irritation). In addition, as demonstrated in two 
independent studies, in vitro skin irritation data obtained with the 
EpiDerm™ model correlate well with human dermal irritation effects 
caused by cosmetics and chemicals [61, 62]. Also pre-validation studies 
on phototoxicity [63, 64] and dermal penetration validation studies [65, 
66] have been performed. A variety of additional testing applications 
using the EpiDerm™ models include cosmetic products testing [61], skin 
metabolism [67-68] genotoxicity [69], nanotoxicity [70,71], and 
pharmacology [72]. 
The EST1000® skin model 
The EST1000® skin model is an in vitro 3D reconstructed human 
epidermal model produced by Cell Systems, Troisdorf, Germany. This 
model has been commercially 
available since 2004 and is used in a wide range of regulatory toxicology 
tests (e. g., irritation, corrosion and phototoxicity studies). EST1000® 
was validated successfully 
and obtained regulatory approval for skin corrosion testing in accordance 
with the OECD test guideline 431 [73]. Currently the EST1000® model is 
undergoing validation for skin irritation. In addition, the model was 
assessed for its utility in skin sensitization testing [74] and is currently 
taking part in a pre-validation study for skin sensitization (personal 
communication). Other applications of both EST1000® model include 
phototoxicity and genotoxicity [75, 76, 77]. Very recently the name of the 
EST1000® model was changed into epiCS®. 
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The Phenion® Full-Thickness Skin Model and the OS-Rep model 
The proprietary Phenion® Full- Thickness Skin Model (Phenion® FT 
model) was originally developed by scientists of the Henkel AG & Co. 
KGaA (Düsseldorf, Germany) in collaboration with the Universities of 
Frankfurt and Munich, and was introduced commercially in 2006. Human 
fibroblasts isolated from biopsies obtained from healthy donors are grown 
in a specially-produced stable matrix equivalent. After the development of 
this dermal equivalent, keratinocytes originated from the same donor are 
seeded on top. Within several days an epidermal tissue featuring all 
typical epidermal layers including a multilayered stratum corneum 
develops. 
The Phenion® Full-Thickness Skin Model exhibits structural and 
physiological properties comparable with native human skin [78]. It is 
primarily used for efficacy studies, skin irritation [79], phototoxicity [80], 
dermal absorption [81], metabolism [82] and genotoxicity studies [83]. 
Henkel also launched the so-called‘Open Source Reconstructed 
Epidermis’, or OSREp model. The Open Source concept supports the 
idea of free public access to information and systems, currently best 
known in the computer software market. When applied to skin models 
“Open Source” means that, once a production method has been 
established, the know how becomes openly available in order to 
empower scientific groups throughout the world to produce the model 
‘internally’, independent of any commercial supplier [84]. The idea of 
a protocol for epidermal model production which can be applied by any 
experienced user was first introduced by Poumay et al. [85]. Based on 
this protocol, which was optimized by Henkel regarding medium 
composition and cell quality, the OS-REp model was established, 
featuring basic epidermal characteristics [86,87]. In addition, to expand 
the scientific knowledge base of this model, it is 
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intended to be used for the toxicological assessment of substances, thus 
making it a viable alternative to animal testing. Clearly, especially for 
regulatory purposes, validated SOP’s and quality criteria for both OS 
model production as well as testing protocol have to be strictly respected. 
Recently the OS-Rep model underwent a successful catch-up validation 
for skin irritation assessment, which has been submitted to EURL-
ECVAM for official regulatory acceptance [88]. 
The StratiCELL® skin model 
The company Straticell, Les Isnes, Belgium, founded in 2005 as spin-out 
of the University of Namur, Belgium, has developed two proprietary in 
vitro skin models. The StratiCELL® reconstituted human epidermis with 
and without pigmentation, is composed of normal human keratinocytes 
and melanocytes cultured in a well-defined 
serum-free medium on a polycarbonate filter at the air-liquid interface. In 
addition, the company provides epidermal models from young/old & 
normal/diseased individuals (atopic dermatitis and psoriasis). Currently, 
the StratiCELL® skin model is preparing for catch-up skin irritation 
validation and the models were also evaluated for usefulness in 
nanotoxicology testing [89]. Additional specific safety applications of the 
StratiCELL® skin model, for assessing genotoxicity and phototoxicity are 
currently being evaluated. 
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The StrataTest® skin model 
The StrataTest® human skin model, developed and commercialized by 
the company Stratatech, Madison, WI, USA, is a fully-stratified, multi-
layered human skin tissue 
composed of both epidermal and dermal components. The epidermal 
compartment is generated by the terminal differentiation of NIKS® 
keratinocytes, a spontaneously 
immortalized cell line, which serves as a unique, consistent and unlimited 
source of human keratinocyte progenitors [90]. The dermal compartment 
of the model contains 
normal human dermal fibroblasts distributed throughout a fibrous 
collagen matrix. The NIKS® cells are nontumorigenic, pathogen-free, 
and have been clinically. 
evaluated as the epidermal component of StrataGraft® skin substitute 
tissue [91]. Unlike skin models that must replenish keratinocyte sources 
periodically as stocks are depleted or utilize cells pooled from multiple 
donors, a uniform keratinocyte source is used to manufacture the 
StrataTest® human skin model. This provides a consistent, reproducible 
test platform. Several studies have described the biological response of 
NIKS®- generated models to chemical compounds [92], antibiotic 
formulations [93], and surfactants [94], signaling proteins [95], and 
environmental factors including hypoxia [96, 97], ozone, cigarette smoke, 
and ultraviolet light [98]. An additional unique feature of the NIKS® 
keratinocytes resides in their ability to be genetically-modified by non-
viral means to generate stably-transfected clones [99, 100]. In vitro skin 
irritation data generated with the StrataTest® model are comparable to 
human in vivo scores [101]. 
Currently the model is preparing for catch-up skin irritation validation. 
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The LabCyte™ skin model 
The LabCyte™ skin model (EPI-model) is produced by Japan Tissue 
Engineering Co., Ltd., Gamagori, Japan,by culturing human epidermal 
cells on inserts. After human epidermal cells have proliferated, exposure 
to the air-liquid intereface causes it to keratinize, creating a cultured 
epidermis model similar to the human epidermis [102]. The EPI-model 
has undergone validation for skin corrosion in accordance with the OECD 
test guideline 431 [103]. More recently the LabCyte™ model has 
undergone a formal catch-up validation study for skin irritation [104] and 
has been included into a new draft version of the OECD TG 439 [105]. 
The Vitrolife-SKIN™ skin model 
The Vitrolife-SKIN™ skin model, produced by Gunze Corporation Ltd, 
Kyoto, Japan, is a commercially available 3D reconstructed skin model, 
which is supplied as a kit containing 24 collagen sponges without cells 
and culture medium. The models need  to be prepared in the laboratory 
(cultivation of cells in sponges) resulting in a 3D skin model composed of 
a dermis and an epidermis with cornified layers as described in the 
literature [106, 107]. The model was recently validated for corrosivity 
[108, 109] and obtained the JACVAM (Japanese Centre for the 
Validation of Alternative Methods) validity statement that the Vitrolife-
SKIN™ corrosivity assay complies with the OECD guideline TG 431 [110]. 
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Introduction 
The existing in vitro skin models reported in literature and described in 
the previous chapter are essentially based on cellularised fibrillar 
exogenous collagen. 
Nevertheless, even if this model are widely used as in vitro dermal 
substitute they represent too simplified model to mimic the complex 
structure of dermis made up on cells embedded in a structured ECM 
composed by collagen, elastin and glycosomminoglycans. As 
consequence an exogenous bovine collagen can not mimic correctly 
such a complex structure and can not allow the recapitulation of pathway 
that in vivo plays a fundamental role in phenomena such as aging, 
photoaging or other events in which the structural proteins of ECM are 
involved. 
The ECM is the non-cellular component present within all tissues and 
organs, and provides not only essential physical scaffolding for the 
cellular constituents but also initiates crucial biochemical and 
biomechanical cues that are required for tissue morphogenesis, 
differentiation and homeostasis. The importance of the ECM is vividly 
illustrated by the wide range of syndromes, which can be anything from 
minor to severe, that arise from genetic abnormalities in ECM proteins 
[1].The ECM is a highly dynamic structure that is constantly being 
remodeled, either enzymatically or non-enzymatically, and its molecular 
components are subjected to a myriad of post-translational modifications. 
Through these physical and biochemical characteristics the ECM 
generates the biochemical and mechanical properties of each organ, 
such as its tensile and compressive strength and elasticity, and also 
mediates protection by a buffering action that maintains extracellular 
homeostasis and water retention. 
Formation of ECM  is essential for processes like growth, wound healing, 
and photoaging etc. For example, an understanding of ECM structure 
 
Chapter 2 
 
- 36 - 
 
and composition also helps in comprehending the complex dynamics of 
tumor invasion and metastasis in cancer biology as metastasis often 
involves the destruction of extracellular matrix by enzymes such as 
serine proteases, threonine proteases, and matrix metalloproteinases. 
In this perspective, we have developed a 3D-human dermis equivalent 
construct with properties similar to native dermis through an engineering 
approach defined modular or bottom-up approach [2-3]. 
One of the major challenges of bottom-up tissue engineering is to 
assemble modular tissues with specific micro architectures into 
macroscale biomimetic engineered tissues. Other challenge is to retain 
the microarchitecture and cellular behavior of modular tissues, while 
creating engineered tissues with robust mechanical properties. 
We started from the realization of human dermis microtissue precursors 
(HD-µTPs) through the seeding of the cell on the microscaffold followed 
by a phase of aggregation of µTPs until the formation of a 3D-Human 
Dermis Equivalent model (called 3D_HDE).  
This model represents a real innovation in tissue engineering and we 
have demonstrated that morphological, biochemical characteristics are 
very similar to native tissue. 
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MATERIALS AND METHODS 
Microscaffold production 
Preparation of porous gelatin microbeads 
Gelatin porous microbeads (GPMs) have been prepared according to a 
modified double emulsion technique (O/W/O) [4]. Gelatin (type B Sigma 
Aldrich Chemical Company, Bloom 225, Mw=l 76654 Dalton) was 
dissolved into 10 ml of water containing TWEEN 85 (6% w/v) (Sigma 
Aldrich Chemical Company). The solution was kept at 60°C. Toluene 
containing SPAN 85 (3% w/v) (Sigma Aldrich Chemical Company) was 
continuously added to the aqueous gelatin solution (8 % w/v) to obtain 
primary oil in water emulsion. The added toluene formed droplets in the 
gelatine solution until saturation. Beads of gelatine containing droplets of 
toluene were produced through the addition of excess toluene (30 ml). 
The overload of toluene allowed the obtaining of a double emulsion 
(O/W/O). After cooling below 5°C, 20 ml of ethanol was added to extract 
toluene and stabilize GPMs. The resulting microspheres were filtered 
and washed with acetone and then dried at room temperature. 
Microspheres were separated selectively by using commercial sieves 
(Sieves IG/3-EXP, Retsch, Germany). GPMs with 75-150 m size range 
were recovered and further processed. Finally the microbeads 
morphology has been examined by means of Scanning Electron 
Microscopy (SEM). 
Crosslinking of GPM 
GPMs have been stabilized by means of chemical treatment with 
glyceraldehyde (GAL), in order to make them stable in aqueous 
environment at body temperature. In particular, GPMs were dispersed 
into acetone/water solution containing 5% of GAL and mixed at 4°C for 
24 h. Then microspheres were filtered and washed with acetone and 
dried at room temperature.  
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HD-µTP precursors characterization 
Human dermal ﬁbroblasts (neonatal HDF ,Cell Applications, Inc, UK) 
were sub-cultured onto 150 mm Petri dishes in culture medium (Eagle’s 
BSS Minimum Essential Medium containing 20% fetal bovine serum, 
100 mg/mL L-glutamine,100 U/mL penicillin/streptomycin, and 0,1 mM 
Non Essential Amino Acids). Cells were maintained at 37°C in humidified 
atmosphere containing 5% CO2. HDF of passages 6-12 and GPM 
crosslinked at 5% (5% GPM) have been used for all experiments. Before 
using dry GPM were sterilized by absolute ethanol sub-immersion for 
24h. Successively to remove completely the ethanol several washings in 
calcium-free and magnesium-free phosphate-buffered saline (PBS) were 
performed. Before cell seeding PBS was removed and replaced with the 
culture medium. HD-µTPs cultivation was initiated by inoculating HDF at 
10 cells bead−1. The culture suspension was stirred intermittently at 30 
rpm (5 min stirring and 30 min static incubation) for the ﬁrst 6h post-
inoculation for cell adhesion, and then continuously agitated at 30 rpm. 
The growth medium was replenished on the first day and every 2 days 
until the end of experiments (9 days in total). From the day 4th 50µg/ml of 
ascorbic acid was added. HD-µTP samples were taken for assay at day 
1, 3, 6 and 9. The rate of disappearance of free cells from inoculated 
microcarrier cultures was determined as an indication of cell attachment 
to microcarriers. During the intermittent stirring phase culture sample 
(500 µl) was taken each hour and allowed to settle for 1 min in an 
Eppendorf tube. The microcarrier-free supernatant was introduced into a 
hemocytometer for cell counting. After counting the free cells in the 
medium with a hemocytometer, the number of cells adhering to 
microbeads (cell/microbead ratio) was evaluated. About 1ml aliquots 
were collected at day 1,3,6 and 9 from spinner culture for the cell 
adhesion assay on the microcarriers. Brieﬂy, 300 µl of the same aliquots 
was transferred to a cell culture dish (w/2 mm grid Nunc) for microcarrier 
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counting, experiments were performed in triplicate. After that the 
microcarriers suspension was placed in the 1,5ml eppendorf tube, gently 
washed twice with PBS, and then treated with trypsin solution to allow 
cell harvesting. Finally, the detached cells were counted using a 
hemocytometer. 
Scanning electron microscopy (SEM) 
SEM was performed to analyze the morphology of microbeads and of 
µTP precursors. The microbeads didn’t need any dehydratation process 
so they were mounted onto metal stubs using double-sided adhesive 
tape and then gold-coated using a sputter coater at 15 mA for 20 min. 
Coated samples were then examined by scanning electron microscopy 
(SEM) (Leica S400). Instead the µTP precursors  needed to be 
dehydratated, the dehydratation was carried out by gradually decreasing 
the water concentration and increasing the ethanol concentration (75%, 
85%, 95% and 100%, and 100% again, each step 20 min at room 
temperature). Finally the samples were treated following the procedure 
explained above for dried samples. 
3D human dermis equivalent model 
HD-µTP molding  
As previously described [5] HD-μTPs suspension was transferred from 
the spinner ﬂask to a 50 ml Falcon centrifuge tube and, after settling, 
transferred by pipetting into the maturation chamber to allow their 
molding in disc-shaped construct (1 mm in thickness, 5 mm in diameter). 
During the filling procedure, the maturation chamber was accommodated 
on a device connected with a vacuum pump to make the process faster 
and to assure that any bubble was in the maturation space.  
This chamber has a “sandwich-like” structure, the center of which there 
is a silicon mold with four blank spaces, where takes place the assembly 
of μTPs. The silicon mold is bounded both on the lower side both on the 
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upper one of two rigid grids of stainless steel characterized by a porous 
network for retaining μTPs and for allow an efficient and homogeneous 
supply of nutrients. Two rings of polytetrafluoroethylene (PTFE) are 
placed on the racks on both sides of the chamber and held together by 
four screws which ensure the closing of the system (fig.1) [6,7]. 
 
 
Figure 1: Assembling maturation chamber(A), showing the configuration of the 
assembling chamber during the assembling process of µ-TPs (a), the silicon 
mould with four empty spaces (b), the rigid mesh with 18 µm pore size (c) and 
the PTFE ring (B); µ-TPs loading (C).  
 
Maturation of 3D-HDE was carried out until 2 weeks in dynamic 
conditions by placing the chamberon the bottom of a spinner flask 
operated at 60 rpm at 37 °C, 5% CO2 and humidity 90%. The medium 
was changed every 2 days and at each medium change ascorbic acid 
was added at a concentration of 50 μg/ml. 
 
Characterization of 3D_HDE model 
ECM morphology and composition 
The samples were fixed in a solution of 4% paraformaldehyde for 30 min 
at room temperature, rinsed twice with PBS buffer solution and soaked 
into a sucrose water solution (2M). After 24 hours samples were 
included in Tissue Tek (Killik) in a suitable mold (Peel-A, Ted Pella INC) 
and submerged in liquid nitrogen vapors for 1 min and then stored at -80 
°C. All samples were cut in slices 5 μm in thickness by using 
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criomicrotome (Leica CM 1850). The cut was oriented so as to view the 
cross section of the samples. 
ECM composition and morphology along the 3D_HDE thickness were 
assessed by performing histological and immunofluorescence analysis 
on transverse sections of sample. 
Histological analyses 
7µm transverse sections of samples were stained using hematoxylin-
eosin (Bio Optica) solutions, Masson tricromic (Sigma Aldrich)  and Picro 
Sirius Red (PSR) (Sigma Aldrich) following standard procedure and 
analyzed by an optical microscope (BX53; Olympus).  
Polarized light images of samples stained with PSR alone were acquired 
with an inverted microscope (BX53; Olympus) with a digital camera 
(Olympus DP 21). A linear polarizer was placed between the light source 
and the specimen, while the analyzer was installed in the light path 
between the specimen and the camera. It is known that the color of 
collagen ﬁbers stained with picrosirius red and viewed with polarized 
light depends upon ﬁber thickness; as ﬁber thickness increases, the 
color changes from green to red [8,9]. 
 
Immunofluorescences analyses 
For immunofluorescences analyses (IF), the slices were permeabilized 
with 0.01% Tritox X-100 in PBS/BSA 3% for 1 hour at room temperature. 
Subsequently, the slices were incubated for 3 hours at room temperature 
with primary antibodies followed by incubation of appropriate secondary 
antibody for 2 hours at room temperature. Moreover Hyaluronic acid  and 
fibronectina were performed respectively as dermal markers: anti-
Hyaluronic acid polyclonal antibody (Abcam), anti-fibronectin monoclonal 
antibody (Sigma). Every antibody monoclonal were produced in mouse 
and the polyclonal antibody were produced in rabbit. The nuclear stain 
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was Sytox Green (Invitrogen) and Dapi staining. The secondary 
antibodies that we used were: 546 Rabbit Anti-Sheep IgG H&L (Abcam), 
Alexa Fluor 546 goat anti-mouse IgG (H+L) (life tecnologies). All 
secondary antibodies was diluted 1:500 in PBS/BSA 3%. 
Collagen structure by second harmonic generation imaging 
Second harmonic generation _SHG_ imaging has recently emerged as a 
noninvasive tool for high-resolution imaging of fibrillar type I collagen in 
tissues. Simultaneous interaction of two near-infrared _NIR_ photons 
with non centrosymmetric structures can result in emission of a single 
photon at exactly half the wavelength of the excitation light. In particular, 
collagen type I produces a very robust SHG signal with a nonlinear 
excitation wavelength between 700 and 1064 nm, allowing  a window of 
detection from 350 to 532 nm. 
Because individual collagen fibrils are the source of the SHG signal, this 
method has the potential to spatially resolve collagen organization at the 
submicrometer level and provide information regarding physiological 
changes in collagen structure that correlate with tissue function.  
The samples for second harmonic generation imaging were prepared as 
previously described, but a slice thickness of 50 μm was choose. Before 
imaging, samples were unfrozen and closed with a microscope cover 
slide together with some droplets of glycerol-water solution in order to 
maintain the natural tissue osmolarity. 
SHG imaging in our samples were performed using a Confocal Leica 
TCS SP5 II femtosecond laser scanning system (Leica), coupled to a 
tunable compact mode-locked titanium:sapphire laser (Chamaleon 
Compact OPO-Vis ,Coherent).The samples were observed by using λex = 
840nm (two photons) and λem=415-425nm. The SHG images, having a 
size of 200µm x 200µm, were acquired with a resolution of 12bit, 
1024x1024 pixel by using a 40X N.A. 1.25 objective. 
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RESULTS AND DISCUSSIONS 
Microscaffold characterization 
Gelatin porous microbeads (GPMs) have been prepared according to a 
modified double emulsion technique (O/W/O) and have been separated 
selectively using a sievers in the range of 75-150 µm size. Afterwards the 
GPMs were stabilized with a chemical treatment with glyceraldehydes in 
order to make stable in aqueous environment and finally have been 
characterized by scanning electron microscopy (SEM). 
 
Figure 2: GPMs morphology: SEM micrographs of 5% GPM (A) and zoom of 
single GMP (B). 
 
The SEM images (fig 2 A,B) showed the GPMs morphology in which are 
clearly visible a good sphericity and a high porosity. 
The images show an overview of the GMPs (fig.2- A) as well as an image 
of a single GMP(fig2-B) in which are visible interconnected pores of 
about 20 µm in diameter, uniformly distributed on the surface and in the 
bulk of GPMs. 
 
Characterization of HD-µTP precursors  
HD-µTPs cultivation was initiated by inoculating HDF at 10 cell to bead, 
corresponding to 105cell*ml-1 and 2mg*ml-1 of microbeads in the spinner 
flask(fig 3). 
The culture suspension was stirred intermittently at 30 rpm for the first 
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6h post inoculation in order to promote the adhesion of the cell to the 
beads [10]. 
 
Figure 3 : Spinner flasks bioreactor incubated 
The disappearance of free cells from the inoculated spinner cultures was 
considered to indicate the attachment of cells to the microcarriers. In the 
figure 4-a is reported the seeding efficiency calculated as [(C0-
Ct)*100]/C0 where C0 is the concentration of the HDF at the inoculum 
time and Ct the concentration of the HDF in the culture medium at each 
hour of the intermittent seeding phase of spinner culture. It was possible 
to observe that seeding efficiency was ≈95%. 
Moreover, the cell adhesion as well as cell proliferation during the 
spinner culture were evaluated at day 1, 3, 6 and 9. In the figure 4-b was 
reported the cells/microbead ratio increasing up to ≈ 100 cell*bead-1.  
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Figure 4 : Cell seeding (a) and cell proliferation (b) of HDF on GPMs. 
Sem images show the morphology of µTP precursors at 9 days of 
spinner culture (fig 5a-b) in which it is clearly visible the dense network 
of collagen which is formed both around microbeads that between the 
microbeads themselves. 
 
Figure 5: sem images of µTP precursor at 9 days of spinner culture. Scale bar 
200µm (a); 100 µm (b) 
 
 
3D human dermis equivalent model 
HD-µTP molding  
The HD-µTC were transferred from the spinner flask in a maturation 
chamber to allow their molding in a disc-shaped construct (1 mm in 
thickness, 5 mm in diameter) (fig. 6) inserted in a dynamic environment 
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allowing tangential flow that guarantee optimal nutrient supply  and 
waste removal through the maturation space during the culture time.  
The culture time has been explored at 2 weeks. 
At 2 weeks of culture it was evident by the images 6 B-C that 5% 
3D_HDE retained the disc shape of the mold, are compact and can be 
handled without any damage. 
The optimization of the filling process has allowed to obtain 
homogeneous and compact biohybrid that retains the shape and size of 
the maturation chamber even after the removal of the same from the 
chamber. The biohybrid removed from the mold disc-shaped, has a 
completely smooth surface, remains intact and shows a certain elasticity 
and firmness. 
 
Figure 6 : HD-µTC molding(A); Two pictures(A,B) of the 3D_HDE obtained. As you 
can see the biohybrid is compact and flexible, the surface is completely smooth. 
 
ECM morphology and composition:  
Histological and immunofluorescences analyses 
ECM composition and morphology along the 3D_HDE thickness were 
assessed by performing histological and immunofluorescences 
analyses.  
The figure 7 shows histological images, respectively, of hematoxylin-
eosin; picrosirius red and masson trichrome staining concerning 
3D_HDE at 2 weeks of maturation. 
In the figure 7-A it is possible to observe that the extra-cellular matrix is  
homogeneous in its composition along the thickness of the sample and 
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the fibroblasts are completely immerse in collagen matrix and the 
elongated nuclear morphology underlines the good condition of the cells 
in their own extracellular matrix.   
 
Figure 7: Hystological image of 3D_HDE:  hematoxylin-eosin (A); picrosirius red (B) 
and masson tricromic(C) staining. Scale bar 50µm. 
The figure 7-B show Picrosirius red staining that allows to discriminate 
the collagen fibers, from mature fibers or type I to immature fibers or type 
III by the use of a polarized light microscope.  
The red signal corresponds to thick mature collagen fibers while the 
green signal corresponds to thin immature collagen fibers. 
Finally, masson tricromic histological staining are reported in the image 
7-C. It is possible to see that collagen (in blue) is uniformly present along 
the whole thickness of sample.  
In  figure 8 are presented some markers of the extracellular matrix both 
for in vitro our model and for native human dermis. All 
immunofluorescence analysis were performed on frozen transverse 
section 7µm thick and  as nuclear dye was chosen dapi (fig 8 A, B) and 
sytox green (fig C,D). 
In detail, the image A and B shows fibronectin in red and dapi as nuclear 
staining, while in the image C and D is shown hyaluronic acid (in red) and 
sytox green for cell dye. Fibronectin is the second most abundant protein 
in ECM, where it is organized into a fibrillar network and in 3D_HDE (fig 
8B) the fibronectin signal is more similar to native tissue( fig 8A). 
Hyaluronic acid is non collagenous component of ECM and, in the 
extracellular space, confers upon tissues the ability to resist compression 
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by providing a counteracting turgor (swelling) force by absorbing 
significant amounts of water. Immunofluorescence staining 
demonstrated, in the 3D-HDE, the presence of hyaluronic acid (fig 8D) 
around cells in ECM and this is concorde with signal offered by native 
tissue (fib 8C). 
 
 
Figure 8:Immunofluorescence images of Human native dermis and 3D_HDE. 
Frozen section were immunostained for fibronectin(red)(A-B) and dapi as nuclear 
stain, hyaluronic acid (C-D) and sytox green as nuclear stain. Scale bar 25µm. 
Collagen structure by SHG imaging 
The collagen fibrils structure was observed by using MPM that allow to 
visualize unstained collagen structure by exploiting SHG. 
The figure 9 shows the SHG signal (gray) and cells (green) of human 
native dermis (fig. 9A) and of 3D_HDE with different magnifications (fig.9 
B-D). In our model is visible the presence of collagen around the cells 
and the presence of collagen secreted from human fibroblasts 
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suggested that the cells not only proliferated but also work correctly like 
natural dermal fibroblasts by secreting collagen. 
Besides, as can be seen in the images 9 B, C, D, the collagen matrix of 
3D_HDE is a denser and more organized fine structure with long fibrils 
similar to native dermis. 
Figure 9: SHG image of human native dermis(A) and of 3D_HDE (B-D). Collagen 
matrix in gray and cells in green. Scale bar 50µm. 
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Conclusion 
In conclusion, we have demonstrated that two-step approach based on 
µTP precursor production and their further association is a viable 
strategy to build-up human dermal tissue equivalent in vitro composed of 
all endogenous ECM components. We have characterized this tissue, 
showing , that from a morphological and biochemically point of view, is 
similar to the native dermis in terms of cellular and extracellular 
components. This in vitro model represents a real innovation in tissue 
engineering and it can be used in to study all the phenomena involved in 
the dermis diseases. 
. 
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Chapter 3 
Endogenous human dermis as a novel in vitro tool to 
quantify UVA-induced ECM alterations and efficacy of 
photoprotectants 
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Introduction 
In this chapter we validated the human dermis equivalent model, as an in 
vitro model to study collagen network re-arrangement and photo-
protectans efficacy under simulated solar exposure. 
Damage to the collagenous extracellular matrix (ECM) that comprises the 
skin connective tissue is a characteristic feature of chronically sun 
exposed human skin, and is thought to underlie the coarse, rough, 
wrinkled appearance that is the hallmark of photoaged skin [1,2].  
Photoaging is mainly caused by UVA radiation, which due to its high 
penetration properties, can reach deeper parts of the skin and affects the 
dermal compartment [3]. In vivo studies have given clear evidence that 
UVA exposure induced dermal structure deterioration causing clinical 
changes observed in photoaged skin. However experimental chronic UV 
exposure are difficult to perform in humans and animals for ethical 
reasons as well as significant costs [4]. On the other hand, neither two-
dimensional conventional cell cultures nor three-dimensional cell cultures 
in exogenous scaffold reproduce physiological conditions as well as 
structural and biological aspects of native dermis. Indeed a biological 
tissue is not a combination of cells within a bundle of inert 
macromolecules, but it is rather an intricate complex of cell and cell-
synthesized matrix that constitute a unicum element regulated by a 
multifaceted homeostatic equilibrium. Cells are regulated and controlled 
by the ECM composition and structure, which, in turn, are synthesized, 
assembled and remodeled by cells. Tissue pathology or dysfunction even 
when arisen from cellular components affects the extracellular space and 
vice versa [5-7]. 
It is widely recognized that alteration of the dermal ECM 
microenvironment due to UV exposure have significant consequences on 
the fibroblast function which produce more MMP and less collagen 
modifying the tissue homeostasis [8]. The existing 3D model are able to 
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recapitulate the cell response occurring after UVA irradiations but, at the 
best of our knowledge no in vitro models can analyzed the alterations, in 
the structure, composition and architecture of dermal ECM. In this study, 
by instructing human dermal fibroblast in synthesizing and assembling 
their own ECM, we realized a dermis like tissue rich in endogenous ECM, 
recapitulating the complex homeostatic equilibrium and dynamical 
reciprocity between the cellular and extracellular space. We hypothesize 
that due to its endogenous nature our model is able to mimic both the 
physiological and pathological status of a native tissue such as 
photoaging. So we performed UVA irradiation and quantitatively linking 
photo-aging process with ECM alteration by multi-photon microscopy 
(MPM), histological and immunofluorescence analysis. We investigated 
the feasibility of using our endogenous human dermal equivalent (HDE) 
to confirm the well-known photoprotective effect of retinoic acid on UVA 
induced damages as well as to determine the effect of Dolichos biflorus 
cell culture extract. The latter was previously demonstrated acting on 
multiple fronts in preventing and protecting skin cells from photodamage, 
thanks to the presence of important flavonoids in its composition [9]. Our 
data demonstrated that HDE allows to deeply investigate the phenomena 
involved in dermis photoaging and correlate the damage at cellular and 
extracellular level with collagenous coarsening and ECM organization. 
 
MATERIALS AND METHODS 
Human dermis equivalent production 
The realization of endogenous HDE has been performed by means of a 
previously reported bottom-up tissue engineering strategy (see chapter 
2). Briefly, Human dermal fibroblasts were sub-cultured into 150 mm 
Petri dishes in culture medium (Eagle’s BSS Minimum Essential Medium 
containing 20% fetal bovine serum, 100mg/mL L-glutamine, 100 U/mL 
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penicillin/streptomycin, and 0,1 mM Non Essential Amino Acids) and 
maintained at 37 °C, 5% CO2 and humidity 90%. Dermal microtissue 
(HD-µTP) were produced by seeding HDF of passages 6-12 on gelatin 
porous microcarriers, in a spinner flask for 9 days and then transferred 
into the maturation chamber to allow their molding in disc-shaped tissue-
construct such as HDE (1 mm in thickness, 5 mm in diameter) as 
previously described. Maturation of HDE was carried out until 2 weeks in 
dynamic conditions by placing the chamber on the bottom of a spinner 
flask operated at 60 rpm at 37 °C, 5% CO2 and humidity 90%. The 
medium was changed every 2 days and at each medium change 
ascorbic acid was added at a concentration of 50  g ml-1. As control an 
exogenous human dermis equivalent was also produced by mixing 
human dermal fibroblasts and collagen type I. In particular, appropriate 
volume of bovine type I collagen (Sigma Aldrich)at concentration of 3 mg 
ml-1 was neutralized by dropwise addition of 0.1 NaOH and immediately 
mixed with 3x104 HDF (passage 5) to yield a final concentration of 2.4 
mg/ml. The solution (300 µl per well of a 24-well transwell plate) was 
placed in an incubator at 37°C for 45 minutes to allow the polymerization 
of the collagen. Throughout the manuscript we referred to this model 
such as fibroblast-populated collagen. 
UVA source and irradiation  
Samples were exposed to UVA radiations by using a UVA lamp (UVP 
lamp 3UV 38, cod. 95035, TERMO SCENTIFIC, WATT 3X8) in order to 
simulate solar exposure. The samples (both 3D-HDE and fibroblast-
populated collagen) were accommodated in multiwell and irradiated for 
15 minutes at final power of 20 Joule/cm2. The UVA lamp was mounted 
on a stable support allowing an exposure distance of 2 cm from the 
sample surface. Samples sterility was guaranteed by performing 
irradiation under biological hood.  
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Sunscreen formulation and evaluation of photoprotection 
Dolichos biflorus cell culture extract was previously characterized for its 
properties to protect skin cell from UV induced damage[9-10] . For our 
experiments a formulation of Dolichos extract at 0.01% was used. As 
positive control retinoic acid (1 µM) was used. Treatments with 
sunscreen were performed by adding Dolichos or retinoic acid in the 
culture medium 4 hours before UVA exposure. To avoid the formation of 
phototoxic products, immediately before performing UVA irradiation, 
culture medium was withdrawn and substituted with fresh PBS solution. 
Samples were divided into four groups:  
 Control (not UVA exposed and sunscreen not treated) 
 UVA (UVA exposed and sunscreen not treated) 
 UVA Dol (UVA exposed and Dolichos treated) 
 UVA Ret (UVA exposed and retinoic acid treated) 
As control for each group, fibroblast-populated collagen was used. At the 
end of UVA exposures PBS solution was removed and fresh medium 
with or without sunscreens was added. The UVA-induced damage and 
sunscreen protecting effects were evaluated 6 and 72 hours after UVA 
exposure for all samples.  
Histological analyses 
All samples were fixed in 4% paraformaldehyde for 30 min at room 
temperature, washed in PBS and soaked into a sucrose water solution 
(2 M). After 24 hours samples were included in Tissue Tek (Killik) in a 
suitable mold (Peel-A, Ted Pella INC) and submerged in liquid nitrogen 
vapors for 1 min and then stored at -80 °C. All samples were cut in slices 
7 µm in thickness by using criomicrotome (Leica CM 1850). 
Hematoxylin-Eosin (H/E) staining was performed in order to evaluate 
ECM morphology and stained samples were analyzed by an optical 
microscope (BX53; Olympus). The cell nuclei were stained by SYTOX® 
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Green (Invitrogen, Life Technologies). The samples were observed by 
using the following filter λex=504 nm and λem=523 nm. Moreover, 
mature and immature collagen morphology was assessed by staining 
7µm transverse sample sections with Picro Sirius Red (PSR) (Sigma 
Aldrich). Then stained sample were observed by using an inverted 
microscope (BX53; Olympus) with a digital camera (Olympus DP 21). A 
linear polarizer was placed between the light source and the specimen, 
while the analyzer was installed in the light path between the specimen 
and the camera.  
The color of collagen ﬁbers stained with Picro Sirius Red and viewed 
with polarized light depends upon ﬁber thickness; as ﬁber thickness 
increases, the color changes from green to red. 
For quantitative analyses Picro Sirius red images were analyzed by 
using image J® software. In order to quantitatively determine the 
proportion of mature (red) and immature (green) collagen fibers, we 
resolved each image into its hue, saturation and brightness (HSB) 
components by using Image J software “color threshold” function. Only 
the hue component was retained and a histogram of hue frequency was 
obtained from the resolved 8-bit hue images, which contain 256 colors. 
We used the following hue deﬁnitions; red 0-51, green 52-120[5,11]. The 
analysis was performed on 20 Picro Sirius Red stained sections of 
sample. About 5 region of interests (ROIs) were examined for each 
section. 
Immunofluorescences analyses 
For immunofluorescences analyses, the 7 µm thick slices were 
permeabilized with 0.01% Tritox X-100 in PBS/BSA 3% for 1 hour at 
room temperature. Subsequently, the slices were incubated for 3 hours 
at room temperature with primary antibodies followed by incubation of 
appropriate secondary antibody for 2 hours at room temperature. The 
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primary monoclonal antibodies used in this study include: anti-MMP1 
polyclonal antibody red (diluted 1:200, Abcam), anti-MMP9 monoclonal 
antibody red (diluted 1:200 Abcam) and Anti-Hyaluronic acid polyclonal 
(diluted 1:50, Abcam). The secondary antibodies used were respectively: 
Alexa Fluor (Life Technologies) 568 goat anti-rabbit, Alexa fluor (Life 
Techologies,) 568 goat anti-mouse and 546 Rabbit Anti-Sheep IgG H&L 
(Abcam), all secondary antibodies was diluted 1:500 in PBS/BSA 3%. 
The samples were investigated by using optical microscope (BX53; 
Olympus). To quantitatively analyze MMPs and HA in each samples, 
images were processed by using image J® software and the signal was 
normalized to the cell number. Cells were counted by using the software 
function “analyzes particles”.  
Second Harmonic generation imaging and GLCM texture 
analysis  
For SHG imaging samples slice 50 µm thick were prepared. Before 
imaging, samples were unfrozen and closed with a microscope cover 
slide together with some droplets of glycerol-water solution in order to 
maintain the natural tissue osmolarity. Samples were investigated by 
confocal microscopy (TCS SP5 II Leica) combined with a MPM where 
the NIR femtosecond laser beam was derived from a tunable compact 
mode-locked titanium: sapphire laser (Chamaleon Compact OPO-Vis, 
Coherent).  
Two-photon excited ﬂuorescence was used to induce second harmonic 
generation (SHG) and obtain high-resolution images of unstained 
collagen structures. The samples were observed by using λex = 840 nm 
(two photons) and λem=415-425 nm. The SHG images, having a size of 
200 µm x 200 µm, were acquired with a resolution of 12 bit, 1024x1024 
pixel by using a 40X N.A. 1.25 objective.  
To quantitatively assess the collagen-related changes, we performed 
gray-level co-occurrence matrices (GLCM) texture analysis by using 
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ImageJ plug-in “Texture” on SHG images [12].  
A running neighbor index allowed calculation of a GLCM matrix per 
neighbor index per SHG image. In detail, we evaluated correlation 
feature and if the correlation falls off sharply with pixel distance, the 
collagen matrix presents distinct, linear fibrils; if it remains elevated as 
pixel distance is increased, the collagen matrix has less defined fibrillar 
structure. In this work, we calculated the correlation curve for distances 
ranging from 1 to 200 pixels (corresponding to 1-40 µm) in the horizontal 
and vertical direction of each optical section that cover a length of 
interest of 40 µm. In such spatial windows the distance at which the 
correlation function fall off represents the correlation length of the 
texture. In particular Correlation curve was calculated versus neighbor 
index and correlation length was obtained by fitting data with an 
exponential low [12,13] 
Statistical analyses 
Data is expressed as mean ± SD. Differences between groups were 
determined using a nonparametric method, Kruskal-Wallis. Significance 
between groups was established for p < 0.05 
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RESULTS AND DISCUSSION 
Micro and macroscopic morphology of endogenous HDE  
To fabricate endogenous HDE, dermal microtissue(HD-µTP) were 
molded in a maturation chamber inserted in a dynamic environment 
allowing tangential ﬂow that guarantees optimal nutrient supply and 
waste removal through the maturation space during the culture time. 
As reported in the Figure 1a, HDE obtained after 2 weeks of culture 
retained the disc shape of the mold, it was compact and could be 
handled without any damage. Histological analyses with Hematoxylin-
Eosin shows that fibroblasts retained the typical cytoskeletal morphology 
and are embedded in abundant endogenous ECM (fig. 1b). Moreover, 
images obtained at MPM show cells (green) embedded in the their own 
collagen network (grey) visualized by means of SHG (fig. 1c). The SHG 
signal was strong indicating a massive collagen ﬁbers deposition and 
organized collagen bundles. 
 
 
Figure 1: Macroscopic view of 3D_HDE model after 2 weeks of culture(a) scale 
bar 3mm; H/E staining (b) of 3D_HDE scale bar 50 µm; SHG signal and 
cells(green) , collagen network(gray), scale bar 50 µm 
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MMPs response in photo-exposed and photo-protected 
samples  
Immunofluorescence analyses were performed in order to evaluate the 
expression of two classes of MMPs involved in photoaging process, 
such as MMP1 and MMP9. The image in Figure 2 shows MMP1 (fig. 2a-
d) and MMP9 (fig.2e-h), 72 hours after UVA irradiation, in details the red 
signal indicates MMPs while the green one indicates the cells stained 
with Sytox green.  
 
Figure 2: : Immunofluorescence analysis of 3D_HDE: Expression of MMP-1 (red) 
and SYTOX® Green (green) (a - d); Expression of MMP-9 (red) and Sytox (green) 
(e- h); quantitative analysis of MMP1/Cell(i) and MMP9/Cell (l) at 6 and 72 hours 
after UVA exposure. Scale bar 25 µm. 
Quantitative investigations of immunofluorescence images show that 
MMP1 (fig.2i) and MMP9 (fig. 2l) per cells in HDE irradiated with UVA 
but not treated with sunscreen (UVA-HDE) increased respectively 1.33 
and 1.68 time compared to the control sample 6 hours after UVA 
irradiation and 1.62 and 1.13 time 72 hours after UVA irradiation. Our 
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results confirmed the photo-protectants actions of Dolichos and retinoic 
acid in decreasing the MMPs production only at the second time points. 
Indeed at 72 hours the value of MMPs of photo-protected samples is 
pushed down to the values of the control. Immunofluorescence for 
MMPs performed on fibroblast-populated collagen confirmed an over-
production in irradiated sample and a down regulation in photo-protected 
sample at both time points (fig 3). 
 
Figure 3: Immunofluorescence analysis of fibroblast-populated collagen. 
Expression of MMP-1 (red) and SYTOX®Green (green) (a-d); Expression of MMP-
9(red) and Sytox (green) (e-h); quantitative analysis of MMP1/Cell(i) and 
MMP9/Cell (l)  at 6 and 72 hours after UVA exposure. Scale bar 100µm. 
 
Collagenous and non-collagenous dermal matrix in 
photo-exposed and photo-protected samples  
Both collagenous and non-collagenous components of endogenous 
ECM have been investigated in order to evaluate the effects due to UVA 
irradiation and the anti-aging action of photoprotective. Mature and 
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immature endogenous collagen in HDE, have been investigated by 
means of Picro Sirius Red (PSR) staining, that allows to discern about 
thin immature collagen fiber (green) typical of type III collagen, and thick 
mature collagen fiber (red) typical of type I collagen (fig.4a-d). Hyaluronic 
acid (HA) has been investigated by immunofluorescence as non-
collagenous component of ECM (fig. 4e-h). Imaging analysis has been 
performed on both PSR images and HA immufluorescence.  
The former show a decrease in both kinds of collagen in UVA-HDE 
compared to control at both time points (fig. 4i-l). In particular the 
difference is more marked at 72 hours for immature collagen, indeed the 
control has a value of 9.4x10-3 ± 3x10-3 (pixel pixel-1) while the UVA-HDE 
has a value of 3x10-3 ± 1x10-3 (pixel pixel-1). Interestingly the 
photoprotected samples have mature and immature collagen amount 
equal to control, demonstrating the photoprotective action of Dolichos as 
well as of its positive control retinoic acid.  
Amount of synthesized HA quantitatively assessed by imaging analyses 
show a significant increase of HA in UVA-HDE compared to control  
(fig.4m). The increase in HA deposition is avoided in the photoprotected 
samples that maintain the value of control; indeed no statistical 
difference is assessed between control sample and photoprotected 
ones, at both time points.  
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Figure 4:Picrosirius Red staining of 3D_HDE (a-d). Scale bar 50 µm. 
Immunofluorescence analysis of 3D_HDE: Expression of Hyaluronic Acid (red) 
and SYTOX® Green (green) (e-h) scale bar 25µm; quantitative analysis of 
Immature collagen(i) and mature collagen (l) and HA at 6 and 72 hours after UVA 
exposure 
Collagen remodeling in photoexposed and photoprotected 
samples 
The collagen fibrils structure was observed by using MPM that allow to 
visualize unstained collagen structure by exploiting SHG. By performing 
(gray-level co-occurrence matrices) GLCM texture analysis [14-16] we 
evaluated the correlation length as parameter indicating the roughness 
of the collagen matrix. SHG imaging has been performed on treated and 
not treated HDE and fibroblast-populated collagen as well, in order to 
highlight responsiveness and structural difference in collagen 
organization between endogenous and exogenous ECM. All samples 
have been observed at the two time points but only images at 72 hours 
have been shown in figure 5a-h. By comparing the SHG images of HDE 
(fig. 5a-d) with those of fibroblast-populated collagen (fig. 5e-h) it is 
possible to note the different organization of the endogenous and 
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exogenous collagen. In detail, in all images of the fibroblast-populated 
collagen sample there is a high background noise compared to clear 
SHG signal, the fibers appear short, thin, loosely packed and with 
randomly local orientation and it is not possible to observe significant 
differences between the UVA, not photo-exposed and photo-protected 
samples. On the contrary in the HDE image is possible to observe an 
intense SHG signal that displays a denser matrix with collagen bundles 
much tighter and more organized compared to fibroblast-populated 
collagen samples. Moreover, in the UVA-HDE sample, the fibrils show 
marked clumping indicating a loss of the fine structure and structural 
organization, while the sample treated with retinoic acid and Dolichos 
have a collagen structure very similar to the control. In order to make 
such observation objective, correlation curve has been calculated at 
both time point for all samples and its behavior has been reported in the 
figure 5(i-l) for sample having endogenous ECM and Figures 5(m-n) for 
sample having exogenous ECM. UVA-HDEs are characterized by the 
highest correlation values indicating collagen matrix coarsening due to 
UVA exposure. In contrast photoprotected sample presents a correlation 
curve very similar to control. The correlation curves of fibroblast-
populated collagen present a completely different behavior. Typical 
collagen coarsening due to photoaging is not detected indeed the 
correlation curve of not photoexposed-fibroblast populated collagen 
appears higher than that of photoexposed-one. 
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Figure 5: SHG images rispectively of 3D_HDE (a-d) and fibroblast-populated 
collagen(e-h) at 72 hours after UVA exposure. Scale bar 50µm; Normalized 
correlation of 3D_HDE after 6 hours(i) and 72 hours (l) of UVA exposure and 
fibroblast-populated collagen after 6 hours(m) and 72 hours (n) of UVA exposure 
In table 1 the correlation length calculated in a windows of 40 µm have 
been reported: according to the behavior of correlation curve, UVA-HDE 
presents the highest correlation length at both time points, 23.10 µm ± 
6.95 µm and 22.65 µm ± 6.9 µm compared to control that presents 
values equal to 17.72 µm ± 6.76 µm and 17.14 µm ±5 µm, respectively 6 
and 72 hours after photoexposure (p<0.05). In the case of 
Photoprotected HDE its correlation length presents the same value of 
the control both for UVA-Dol HDE and UVA-Ret HDE. In contrast, the 
value of the correlation length of photoexposed fibroblast-populated 
collagen construct decrease compared to control 6.85 µm ± 3.3 µm vs 
12.69µm ± 9.8µm. 
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Conclusion 
In the present chapter, HDE models have been realized to study UVA-
induced dermal matrix damage and the efficacy of photoprotecants in 
preserving the structure and composition of the dermal ECM.  
We induced the photodamage with a UVA dose that allowed 
physiological survival of the model but assured the expression of specific 
UVA-induced alterations [4]. 
It is known that UV irradiation during excessive and prolonged sun 
exposure can cause severe acute damage and also be responsible for 
long-term effects such as photoaging of the skin. The structural 
consequences of photoaging are mainly evident in the ECM-rich dermis 
where key proteins are particularly susceptible to photodamage. 
Exposure to UVA, in particular, induces extensive changes in the 
composition and architecture of the ECM-rich dermis [17]. It has been 
demonstrated that UVA dermal effects do not depend on an epidermal 
response [4], as consequence since the aim of the present work is to 
investigate the UVA effect on the endogenous dermis, a dermal 
equivalent model without epidermis has been produced. It is well known 
that MMP have an important role in photoaging process [18,19]. In 
particular, MMP1 acts directly on collagen I. MMP9 acts as a non-
specific collagenase, once the collagen has been cleaved by MMP1 it is 
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further broken by MMP9. According to literature we found an increase of 
MMP1 and MMP9, and a decrease in the collagen type I and III in the 
sample UVA-treated. Regarding the photoprotecants, we tested retinoic 
acid a lipophilic molecule well known for its anti-aging and anti-UVA 
effects [20], and Dolichos biflorus, a cell culture extract that has been 
recently demonstrated [9] to protect cellular components from photo-
damages due to the presence of flavonoids and their derivatives in its 
composition. We found that in UVA-Dol and UVA-Ret, MMPs induction is 
blocked only 72 hours after UVA irradiation. On the other hand, 
immature and mature collagen synthesis in the same samples was 
preserved and maintained at the same value of the control both at 6 and 
72 hours after UVA irradiation. We hypothesized that Dolichos and 
retinoic acid due to their antioxidant activity [9] are capable of 
scavenging the free radicals minimizing the damage to the proteins and 
in particular preserving the disassembling and the collagen degradation 
both at 6 and at 72 hours after UVA irradiation, as confirmed also by 
SHG imaging [21-23] . 
Otherwise in fibroblast-populated collagen gel culture, Dolichos as well 
as retinoic acid blocked MMPs induction both at 6 and 72 hours after 
UVA irradiation.  
We argued that due to the exogenous nature of the ECM in fibroblast-
populated collagen gel culture, the antioxidant action of photoprotecants 
is engaged exclusively in the protection of the cells.  
The dynamic interplay between cells and its own ECM plays a crucial 
role in regulating tissue function and tissue responsiveness to an 
external stimulus. Previous work demonstrated that the lack of collagen I 
synthesis in photodamaged dermis was not because of irreversibile 
damage to fibroblasts collagen-synthetic capacity, but the interaction of 
fibroblast with a photo-damaged dermis induced a depressed collagen 
synthesis. Indeed, while in photodamaged dermis collagen fibrils are 
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shortened, thinned and disorganized in healthy dermis fibrils exists as a 
highly organized matrix. Normal function of fibroblasts in dermis requires 
appropriate interactions with collagen fibrils and these interactions 
cannot be achieved when the fibrils are fragmented [24]. SHG imaging, 
allowing the visualization and quantification of collagen matrix change 
also in vivo, is becoming an intrinsic biomarker for evaluating tissue 
health-status [25]. 
Our in vitro model, consisting in fibroblasts embedded in their own ECM, 
is a unique model allowing the study of collagen and its degeneration 
due to photoaging. Indeed according to study performed in vivo on 
photoaged skin [13], we are able to quantify the collagen structure by 
using GLCM texture analysis and evaluating the difference between the 
denser and fine structure ﬁbrils collagen matrix of the normal dermis, 
and the loss of ﬁne structure and structural organization of the 
photoexposed dermis. This result could not be reached with the 
fibroblast-populated collagen gel cultures, that even if widely used as 
“dermal equivalent”, can replicate the photodamage of human dermis, 
only partially (i. e. cellular level). Indeed, when a GLCM texture analysis 
was performed on SHG images from fibroblast-populated collagen gel, 
since only exogenous collagen was present, no typical “dermis-aging 
behavior” was detected. In other words, when fibroblasts are seeded in 
exogenous biomatrices, the cross-talk with its extracellular space is 
limited to basic functions such as: adhesion, migration and traction of 
collagen fibers [26]. The change in correlation length demonstrated that 
our model responded to an external stimulus as a real tissue, and this is 
due to the presence of the cell-synthesized ECM organized in a 3D 
fashion. Moreover since our HDE is a complex of cell within their own 
ECM, which is composed not only by collagen but also other proteins, 
we could also investigate the effect of photoaging on HA production. In 
previously studies by Tzellos et al. [27] the expression of HA in 
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photoexposed and photoprotected human skin tissue specimens 
obtained from the same patient, has been investigated. They reported 
that photoexposed skin was associated with increased levels of 
fragmented HA having lower molecular mass, as compared with 
photoprotected skin, indicating that alterations in HA homeostasis are 
implicated in photoaging. They quantified HA increase both by elisa 
assay and electrophoresis of the total GAG isolated and puriﬁed from 
photoprotected or photoexposed skin. According to these data, we found 
an over-production of HA in UVA treated sample while the 
photoprotected sample maintained the same value of the control, 
indicating that both Dolichos and retinoic acid were able to protect HA 
from damage due to UVA. The capability of retinoic acid to both induce 
sub-epidermal repair zone of new collagen and reduce abundant GAGs 
present in photoaged skin, were already demonstrated in animal model 
[28]. The possibility to have an in vitro platform, such as HDE, to 
investigate the organization and assembly of collagen, as well as 
deposition of other fundamental components of ECM, presents important 
consequence not only in dermatology but also in cosmetology science; it 
opens the possibility to investigate in vitro cosmetic function previously 
assessable only in vivo. Indeed, in our study we can assess the capacity 
of Dolichos, not only to protect the dermis from MMPs overproduction 
and collagen decrease, but we can also to get information about its 
capacity to protect ECM by collagen coarsening. It is important to point 
out that collagen synthesis is regulated by interaction between 
fibroblasts and ECM; in photodamaged skin collagen fibrils are 
shortened, thinned and disorganized, as consequence fibroblasts are 
inhibited in synthesizing collagen [8]. This dynamic reciprocity between 
the cellular and extracellular space is fundamental for the tissue 
functions and can be obtained only when cells are embedded in their 
own ECM. In conclusion our system, due to its endogenous nature, 
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could represent a valuable tool to study tissue status in vitro both at cell 
and extra-cellular level, respectively. Since in both dermatology and 
cosmetology science, there is a strong need to replace in vivo model 
with a more realistic, reliable and cost-effective platform for rapid 
screening, our study pave the way to the development of a new class of 
in vitro tissue model that correctly reproduce in composition and 
organization the extracellular space, leading to the possibility to study in 
vitro the effects of change of human dermis (e.g. by aging) on selected 
aspect of both cellular and extracellular components. It is conceivable 
that a full human skin equivalent could be engineered starting from the 
dermis equivalent realized and either the effect of an external stimuli 
(UVR, drug, cosmetics, toxin..) on dermis and epidermis could be 
studied. 
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Chapter 4 
A human skin equivalent model as in vitro testing 
platform for bioactive molecules 
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Introduction 
The development of effective and alternative tissue-engineered skin 
replacements to autografts, allografts and xenografts has became a 
clinical requirement due to the problems related to source of donor tissue 
and the perceived risk of disease transmission [1]. 
However, human skin equivalent relevance is correlated not only to their 
clinical and surgery applications, but also as reliable testing platform 
alternative to animal testing in the dermo-cosmetical field . The scientific 
community supports animals, which are subjected to considerable pain 
and distress during toxicity testing with final results scientifically 
unreliable because humans and animals can have different reactions to 
the same chemical. For this reason, animal testing for cosmetics has 
been banned in the European Union and a new law also strengthens the 
ban on the sale of products from third countries tested on animals by 
March 2013 [2]( see chapter 1). 
To meet these needs, in vitro fabrication of human skin tissue, that mimic 
the biochemical and morphologic properties of native human skin, known 
as skin equivalent cultures, has opened new avenues in the study of skin 
biology. 
These skin equivalent models consist mainly of keratinocytes that are 
cultured on a dermal substitute for approximately two weeks at the air–
liquid interface, which allows for epidermal differentiation and 
development of stratified layers [3-7]. Until now, very scarce importance 
has been given to the realization of a skin model made up by both dermis 
and epidermis parts. Great parts of the existing human skin equivalent 
models used as in vitro testing platform [8-13] have been made up by an 
epidermis on a polycarbonate mesh or on exogenous matrix. Obviously, 
this matrix do not mimic the real structure of dermal tissue. 
In this chapter, we developed a 3D human skin equivalent model (called 
3D HSE) based on endogenous ECM in dermal and epithelial 
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compartment. We used the dermis equivalent described in the second 
chapter to seed keratinocytes and performing an organotypic culture in 
order to realize the final 3D skin equivalent model. 
First of all we described the optimal conditions to build up the epidermis 
and the final skin equivalent, then we demonstrated how the model can 
be used as testing platform for study photoaging process both at dermis 
and epidermis level. 
MATERIALS AND METHODS 
Fabrication of 3D human skin equivalent 
The realization of human dermis in vitro is similar to that described in 
chapter 2. 
Briefly, human dermal fibroblasts were sub-cultured into 150 mm Petri 
dishes in culture medium and maintained at 37 °C, 5% CO2 and humidity 
90%. Dermal microtissue (HD-µTP) were produced by seeding HDF of 
passages 6-12 on gelatin porous microcarriers with 4% of 
glyceraldehydes crosslink, in a spinner flask for 9 days and then 
transferred into the maturation chamber to allow their molding in disc-
shaped tissue-construct such as HDE (1 mm in thickness, 5 mm in 
diameter) as previously described.  
Maturation of HDE was carried out until 6 weeks in dynamic conditions 
by placing the chamber on the bottom of a spinner flask operated at 60 
rpm at 37 °C, 5% CO2 and humidity 90%. The medium was changed 
every 2 days and at each medium change ascorbic acid was added at a 
concentration of 50  g ml-1. 
After 6 weeks of culture, under dynamic conditions, the human 
equivalent dermis has been removed from the maturation chamber and 
moved to trans-well (Corning Castar 3.0µm pore size tissue culture 
treated polycarbonate membrane sterile)waiting for seeded with 
keratinocytes in order to obtain the epithelial layer. 
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Extraction of keratinocyte from skin biopsy 
Skin sample derived from reduction surgery with the informed consent of 
the patient.  
Under sterile conditions, the biopsy was rinsed more times with PBS in 
order to remove traces of blood, after we put biopsy in PBS/2% 
pen/strep(P-S) solution at 4° C for about 2h and then we remove hairs 
from the top and all fat and tissue remnants from the bottom side keeping 
the biopsy in a cold solution of PBS/1% P-S. 
Cut skin into strips of about 3mm width. Transfer strips into new small 
petri dish, wash with PBS (important: do not use PBS with calcium and 
magnesium at this step). Incubate skin strips with Dispase solution 
(2U/mL; about 5-10 ml for 6cm² of skin) that all strips are covered with it; 
incubate over night on rotating plate to 160 rpm for 16h to 18h. 
The day after, check sterility control for contaminations; and control if 
after 16h the epidermis has removed from dermis (you can see this at the 
edge where epidermis is partly detached from dermis. If so: stop 
digestion by transferring skin strips to PBS; if not: incubate for 2 more 
hours; do not incubate the skin strips for more than 20h in Dispase as 
this will strongly harm your cells). After transferring the skin strips to PBS, 
wash them once to stop the Dispase reaction. Separate epidermis from 
dermis with tweezers. Cut epidermis into small pieces and transfer 
pieces into preheated in 5mL 0,05% Trypsin/EDTA, wash petri dish with 
another 5 mL Trypsin/EDTA and transfer it to the tube- Incubate 
Trypsin/EDTA (with cutted epidermal pieces) for 5 min at 37°C water 
bath, vortex shortly every 1-2 min (important: the water bath temperature 
has to be 37°C, therefore do not place large cold flasks into it as this 
would reduce the temperature). Stop enzyme reaction by adding 1 mL 
FBS. Resuspend solution for 5 min (plastic single-use pipette) to 
separate cell clumps Strain solution by transferring it to new tube through 
cell strainer. Use the same pipette with prepared 10 mL PBS solution to 
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wash the tube, the single-use pipette and finally transfer solution through 
cell strainer, too. Centrifuge: 5 min 1200 rpm. Re-suspend cells in culture 
media and count cells. Seed cells into flasks: 8*10³ cells per cm². After 3 
days 2nd medium change (cells should feature characteristic morphology 
now). Let cells culture up to 80% confluency before detaching and 
seeding dermis equivalent (not more as keratinocytes will start to 
differentiate).  
The choise of colture medium is important in order to obtain 
undifferentiated keratinocyte. In this case, we used  KGMTM-2, which is 
based on an optimised formulation and is serum-free. The medium 
contains the base medium, separate vial of calcium chloride and 
supplementary mix such as: GA( gentamicin), transferrin, epinephrine, 
hydrocortisone, insulin, H-egf, BPE (bovine pituitary extract). 
Realization of epidermis layer  
Before making the keratinocytes seeding of 3D_human dermis 
equivalent, is carried a coating of fibronectin in order to enhance cell 
adhesion. Human fibronectina (Sigma Aldrich) is diluted in salt solution 
of PBS to a concentration of 50 µg/ml  than coat the dermis equivalent 
with a final volume of 50µl for single sample. Allow to air dry, under 
sterile conditions, for 45 minutes at room temperature. During this time, 
the culture medium was prepared. In this phase, the culture media 
contains the base medium with 0.1% GA, 0.1% transferrin, 0.1% 
epinephrine, 0.1% hydrocortisone,0.1% insulin, 0.1% H-EGF, 0.4% BPE 
, 5% FBS, 1%P/S and calcium chloride at 0.06µM. Afterwards, the 
keratinocytes in the plate are detached, so wash the keratinocytes 3 or 4 
times with PBS/EDTA 0.01M leaving in contact for a few second and 
after, trypsinize keratinocyte colonies with trypsin/EDTA for 5 min at 
37°C to obtain a single cell suspension. Once cells have detached, 
gently resuspend them in keratinocyte media, count cells and add the 
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appropriate number of cells to a 15-mL tube so that there will be enough 
cells (150.000 cells/insert) to seed onto the desired number of inserts. 
Centrifuge at 1200rpm for 5 min and. At this time, the cells can be 
seeded directly onto the dermis equivalent; resuspend the keratinocytes 
so that they are in the small volume needed for plating onto the matrix. It 
is important to resuspend cells in a small volume as 150,000 cells will be 
seeded onto the small surface area of the connective tissue (0.5 cm 
diameter). Gently dislodge the cell pellet and transfer it to a 1.5-mL 
sterile Eppendorf tube with a 1-mL plastic pipet. Gently resuspend the 
cell pellet in the eppendorf tube with a 200-μL pipetman until it is cloudy 
and well suspended and transfer 3.5 μL of the cell suspension to the 
center of the dermis equivalent. Do not touch for 10 min to allow cells to 
begin to attach. Incubate at 37°C for 40–80 min without any media to 
allow the keratinocytes to fully adhere. 
After 3 hours cultures are maintained submerged (fig 1) for 6 days, so the 
medium was added first on the bottom of the well and after the rest of 
volume gently into the insert top the keratinocytes. The following day, the 
medium  was change with the only different that the FBS concentration is 
3%. The medium was change every two days with the only different that 
the concentration of FBS switches from 3% (third day after seeding) to 
0% (fifth day after seeding). After 6 days of submerged conditions, the 
cultures are raised to the air/liquid interface for 14 days. In this phase, 
the culture media contains the base medium with 0.1% GA, 0.1% 
transferrin, 0.1% epinephrine, 0.1% hydrocortisone, 0.1% insulin, 1%P/S 
and calcium chloride at 1.88 µM. 
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Figure 1: realization of 3D human skin equivalent: phases of keratinization 
process. 
Characterization of human skin in vitro model 
In the first part, in order to assess the morphology of the tissue as well as 
the morphogenesis of epidermal differentiation, were conducted 
macroscopic analysis through the stereomicroscope (Olympus) and 
microscopic analysis such as histological and immunofluorescence. After 
the end of the air-liquide interphase, samples were fixed in 4% 
paraformaldehyde for 30 minutes at room temperature, wash them in 
PBS and then placed into a sucrose 2M solution for max 24 hours at 
room temperature. The day after the samples were included in Tissue 
Tek (Killik) in a suitable mold and submerged in liquid nitrogen vapors for 
1 min and then stored at -80 °C. All samples were cut in slices 5 μm and 
50µm in thickness by using criomicrotome. The cut was oriented so as to 
view the cross section of the samples.ECM composition and morphology 
along the 3D HSE were assessed by performing histological and 
immunofluorescence analysis on 5 μm transverse sections of sample 
and by SHG analysis on 50 μm transverse sections of sample for the 
assessing of the collagen structure 
Histological analyses 
Hematoxylin-eosin, picrosirius red staining were performed after 
hydratation of the sample, finally the sections were mounted with 
histomount mounting solution (INVITROGEN) on coverslips following 
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standard procedure  by an optical microscope. 
Immunofluorescences analyses 
For immunofluorescences analyses (IF), the slices were permeabilized 
with 0.01% Tritox X-100 in PBS/BSA 3% for 1 hour at room temperature. 
After, the slices were incubated for 3 hours at room temperature with 
primary antibodies followed by incubation of appropriate secondary 
antibody for 2 hours at room temperature. Moreover Keratin 10 (K10), 
Keratin 14 (K14), P63, Ki67 epithelial markers were performed using 
respectively: keratin 10 polyclonal antibody (diluition 1:500; Covance), 
keratin 14 polyclonal antibody (diluition 1:1000; Covance), Anti-p63 
monoclonal antibody (diluition 1:100;abcam), anti laminin V monoclonal 
antibody (diluition 1:500; abcam).  Every antibody monoclonal were 
produced in mouse and the polyclonal antibody were produced in rabbit.  
The secondary antibodies that we used were: Alexa Fluor 546 goat anti-
rabbit IgG (H+L) (diluition 1:500; Life technologies), Alexa Fluor 488 goat 
anti-mouse IgG (H+L) (diluition 1:500; life tecnologie), Alexa Fluor 546 
goat anti-mouse. IgG (H+L) (diluition 1:500; life technologies). The 
nuclear stain was 4',6-diamidin-2-fenilindolo (DAPI). 
 
Validation of 3D human skin equivalent model as in vitro 
testing platform for bioactive molecules  
As was done on the 3D_human dermis equivalent (see chapter 3), we 
have used this 3D HSE model as in vitro screening platform of anti –UVA 
molecular compound. In particular we evaluated successive alteration 
and recovery of epidermal and dermal morphogenesis with 
photopretectans after specific UVA-damages. We examined effects of 
active compound such as formulation of Dolichos extract at 0.01% from 
topical and topical&systemic application on structure and organization of 
epidermis and dermis. 
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In epidermis, the investigations focused on potential effect of UVA 
exposure on keratinocyte proliferation (Ki67) and p63 expression, since 
P63 is essential to normal epidermal development.  
In dermis, expression of metalloproteases, amount of deposited dermal 
components   and re-organization of collagen matrix after UVA exposure 
were examined. 
UVA source and irradiation  
Samples were exposed to UVA radiations by using a UVA lamp in order 
to simulate solar exposure. The samples were accommodated in 
transwell, and irradiated in PBS solution for 15 minutes at final power of 
20 Joule/cm2. The UVA lamp was mounted on a stable support allowing 
an exposure distance of 2 cm from the sample surface.  
Sunscreen compound and photoprotection 
Dolichos biflorus cell culture extract was previously characterized for its 
properties to protect skin cell from UV induced damage [14,15] . For our 
experiments a formulation of Dolichos extract at 0.01% was used. As 
positive control retinoic acid (1 µM) was used. Treatments with 
sunscreen were performed 4 hours before UVA exposure by adding 900 
µl Dolichos or retinoic acid  in the insert of transwell and 5µl on the top of 
epidermal layer for the topic and systemic application and by adding 5µl 
on the top of epidermal layer for only topically application. To avoid the 
formation of phototoxic products, immediately before performing UVA 
irradiation, culture medium was withdrawn and substituted with fresh 
PBS solution. Samples were divided into six groups:  
 Control (not UVA exposed and sunscreen not treated) 
 UVA (UVA exposed and sunscreen not treated) 
 UVA Dol T&S (UVA exposed and topic&systemic Dolichos treated) 
 UVA Dol Top (UVA exposed and topic Dolichos treated) 
 UVA Ret T&S (UVA exposed and topic&systemic retinoic acid 
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treated) 
 UVA Ret Top (UVA exposed and topic retinoic acid treated) 
At the end of UVA exposures PBS solution was removed and fresh 
medium with or without sunscreens was added. The UVA-induced 
damage and sunscreen protecting effects were evaluated 6 and 72 
hours after UVA exposure for all samples.  
Histological and immunofluorescences analyses 
Collagen morphology was assessed by staining 5µm transverse sample 
sections with PSR (Sigma Aldrich). Then, stained sample were observed 
by using an inverted microscope with a digital camera. Quantitative 
imaging analyses were performed as previously reported (see cap 3) 
[16,17]. For immunofluorescences analyses, The primary monoclonal 
antibodies used in this study include: anti-MMP-1 polyclonal antibody 
(Abcam); anti-MMP-9 monoclonal antibody (Abcam);  keratin 10 
polyclonal antibody ( Covance), Anti-p63 monoclonal antibody (Abcam), 
anti- Ki67 polyclonal antibody( Abcam).  The secondary antibodies used 
were: Alexa Fluor 568 goat anti-rabbit; Alexa fluor 568 goat anti-mouse; 
Alexa Fluor 488 goat anti-mouse The cell nuclei were stained by Sytox® 
Green and 4',6-diamidin-2-fenilindolo (DAPI).). To quantitatively analyze 
MMPs in each samples, images were processed by using ImageJ® 
software and the signal was normalized to the cell number. For the 
analysis of p63, Ki67 and Cells we used the Image J software with the 
function “Analyze particles”.  
Collagen structure by second harmonic generation imaging 
The collagen matrix was observed with second harmonic generation 
_SHG_ imaging.  SHG imaging in our samples were performed using a 
Confocal Leica TCS SP5 II femtosecond laser scanning system (Leica), 
coupled to a tunable compact mode-locked titanium:sapphire laser 
(Chamaleon Compact OPO-Vis ,Coherent). The samples were observed 
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by using λex = 840nm (two photons) and λem=415-425nm. The SHG 
images, having a size of 200µm x 200µm, were acquired with a 
resolution of 12bit, 1024x1024 pixel by using a 40X N.A. 1.25 objective. 
We used Sytox green as nuclear staining. As  well as made to the only 
dermis model (see chapter 3) to quantitatively assess the collagen-
related changes, GLCM texture analysis by using ImageJ® plug-in 
“Texture” on SHG images has been performed [18]. In details, we 
evaluated the correlation feature for distances ranging from 1 to 200 
pixels (corresponding to 1-40 µm) in the horizontal and vertical direction 
of each optical section that covered a length of interest of 40 µm. In such 
spatial windows the distance at which the correlation function fell off 
represented the correlation length of the texture. In particular the 
correlation curve was calculated vs. the neighbor index and the 
correlation length was obtained by fitting data with an exponential low 
[18, 19]. 
Statistical analyses 
Data are expressed, as mean ± SD and show the results from three 
independent experiments. Differences between groups were determined 
using a nonparametric method, Kruskal-Wallis. Significance between 
groups was established for p < 0.05. 
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RESULTS AND DISCUSSION 
Macroscopic analyses of 3D HSE 
The image 2a shows a macroscopic top view of 3D HSE samples in 
transwell after the air liquid interface It is possible to note the presence 
of a spot at the center of the sample, indicating the occurrence of a 
proper epithelial differentiation; likewise in the image 2b is shown a top 
view of HSE at the stereomicroscope. Also in this case there is the 
presence of small agglomerates which show the presence of melanin 
pigments in determining skin color. 
 
Figure 2 : Macroscopic view of 3D HSE ,(a)top view of HSE in transwell after 
air-liquid interface. Scale bar 10 mm and (b) top view of sample at 
stereomicroscope. Scale bar 1 mm 
Morphology and composition of skin equivalent 
Histological and immunofluorescence analysis; SHG imaging were 
conducted to observe tissue structure and marker localization of cells in 
3D HSE. 
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Figure 3: Hematoxylin and eosin and picrosirius red staining of histological section 
with thick 5 µm of 3D HSE with endogenous dermis . Scale bar:  (a,d) is 100 µm,( b, 
e) is 50 µm and (c, f) is 25 µm. 
Due to histological analysis of hematoxylin/eosin (fig 3a,b), it is possible 
to observe the differentiation of the epithelial layer. Figure 3c, due to the 
high magnification, highlights the greater degree of  epithelium 
architecture, from the basal layer to the corneum one that present cells 
without the nucleus.  
Moreover both the histological images  given from picrosirius red (fig. 3d-
f) and SHG imaging (fig.4) confirm the presence of a dense network of 
collagen matrix with well organized fibers. Furthermore the collagen 
matrix is very closely to that of native tissue 
 
Figure 4: SHG image of human native skin(a) and of 3D HSE (b).  
Scale bar 25µm 
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To evaluate the capacity of primary keratinocytes to generate a correct 
epidermal tissue on our 3D human dermis equivalent, we detected the 
epidermal markers by a immunofluorescence analysis.  
In figure 5 are shown single markers of each layer which constitute the 
epithelial tissue starting from the basal layer to the spinus stratum. In 
figure 5a is shown expression of Keratine 14 (K14) and nuclei with dapi 
dye. K14 expression is confined to the basal and spinous layer; figure 5b 
shows the correct morphological  expression of transcriptional factor p63 
in green in the basal layer; finally in figure 5c it is possible to note the 
presence of keratin 10 around keratinocytes of the suprabasal layer. 
 
Fugure 5: Immunofluorescence analysis of histological section with thick 5 µm 
3D HSE show keratin 14(red) and Dapi as nuclear staining (a); transcriptional 
factor P63 localized only in the basal layer (green) and keratine 10(red) (b); 
keratin 10 (red) and Dapi(blue)(c). Scale bar 50 µm. 
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Alteration and Recovery of epidermal and dermal 
morphogenesis with photoprotectans compound after specific 
UVA exposure 
Assured that our 3D skin equivalent model is similar to a native tissue 
from morphological and structural point of view, we assessed whether it 
was able to respond to an external stimulus like that UVA exposure and 
specifically we evaluated the action of UVA rays both on derma and 
epidermis layer. 
Effect of UVA and protecants on the dermis layer 
Immunofluorescence analyses were performed in order to evaluate the 
expression of MMP-1 and MMP-9. In figure 6 is shown expression of 
MMP-1 (fig. 6 a-f) and MMP-9 (fig. 6g-n), 72 hours after UVA irradiation; 
in detail, the red signal indicates MMPs while the green one indicates the 
cells stained with Sytox Green. 
Quantitative investigations of immunofluorescence images show that 
MMP-1 (fig.6o) and MMP-9 (fig.6p) per cells in 3D HSE irradiated with 
UVA but not treated with photoprotectants increased respectively 1.85 
and 1.71 times compared to the control samples 6 hours after UVA 
irradiation and 2.14 and 2.21 times 72 hours after UVA irradiation.  
In addition the results showed that the action of Dolichos and retinoic 
acid are able to decrease the MMPs production both 6 hours to 72 hours 
bringing its expression to the value of non photo-exposed sample. 
Also, it is important to note that the only topical application of 
photoprotectans fails to protect the samples by the increase of  
metalloproteinases expression. 
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Figure 6 : Immunofluorescence analysis of 3D HSE: Expression of MMP-1 (red) 
and SYTOX®Green (green) (a-f); Expression of MMP-9 (red) and Sytox (green) 
(g-n); quantitative analysis of MMP1/Cell(o) and MMP9/Cell (p)  at 6 and 72 
hours after UVA exposure. Scale bar 100µm. 
Collagenous components of endogenous ECM were both investigated in 
order to evaluate the effects of the UVA irradiation and the anti-aging 
action of photoprotective. Collagen type I in 3D HSE were investigated by 
means of Picro Sirius Red (PSR) staining (fig 7 a-f). Quantitative analysis 
on PRS images showed a decrease of collagen irradiated sample(UVA) 
compared to the control at both time points (fig 7g). In particular, the 
irradiated sample( UVA) had a value of 16.1x10-2±0.7x10-2 and 15.9x10-
2±1x10-2, respectively at 6 and 72 hours after UVA exposure, while the 
control sample had a value of 22.6x10-2±4x10-2 and  
22.4x10-2±3x10-2. Interestingly, the photoprotected samples, both topic 
and topic&systemic applications, had collagen amounts equal to the 
control, demonstrating the photoprotective action of Dolichos, as well as 
of its positive control, retinoic acid.  
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Figure 7: Picrosirius red staining (PRS) of 3D HSE (a-f). Scale bar 100 µm; 
quantitative analysis of PRS  at 6 and 72 hours after UVA exposure(g). 
Remodeling of Ecm with and without photoprotectans by  
SHG signal after UVA irradiation 
The remodeling of ECM and in particular of collagen fibrils structure was 
evaluated by SHG (second harmonic generation) signal using 
multiphoton microscopy. By performing GLCM texture analysis (gray-
level co-occurrence matrices) [20-22] we evaluated the correlation 
feature or correlation curve as a parameter indicating the fibril and 
separation of collagen bundles as a as a function of pixel distance. In 
detail, if the correlation falls off sharply with pixel distance, the collagen 
matrix presents distinct, linear fibrils as in the case of young and healthy 
skin; if it remains elevated as pixel distance is increased, the collagen 
matrix has less defined fibrillar structure as in the case of aging and 
photoaging skin. We also evaluated a values of correlation (decay) 
length by fitting the correlation curve with a single exponential decay 
function. SHG imaging was performed on treated, non-treated 3D HSE 
model in order to highlight responsiveness and structural differences in 
collagen organization. All samples were observed at the two time points 
but only images at 72 hours are shown in figure 8 (a-f).  
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Figure 8 : SHG images 3D HSE model (a-f) at 72 hours after UVA exposure. Scale 
bar 25µm; Normalized correlation of 3D-HSE after 6 hours(g) and 72 hours (hl) of 
UVA exposure and correlation length(i). 
In the UVA and non treated sample (UVA), the fibrils show marked 
clumping indicating a loss of the fine structure and structural 
organization, while the samples treated with retinoic acid and Dolichos 
have a collagen structure very similar to the control. In order to make 
such an observation objective, the correlation curve was calculated at 
both time points for all samples and its behavior was reported in figure 8 
(g-h). The UVA samples are characterized by the highest correlation 
values indicating a collagen matrix coarsening due to UVA exposure. In 
contrast, the photoprotected sample presents a correlation curve very 
similar to the control. 
The correlation lengths calculated in a window of 40 µm were reported in 
figure 8i: according to the behavior of the correlation curve, UVA-HDE 
presents the highest correlation length at both time points compared to 
the control (p<0.01). In the case of photoprotected HDE samples, their  
correlation length presents the same value of the control.  
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Effect of UVA and photoprotecants on the epithelial layer 
In order to assess the effects of UVA exposure on epithelial layer, 
immunofuorescences analyzes were conducted; in particular we 
investigated the expression of respectively Ki67 protein which is strictly 
associated with cell proliferation and p63 marker. The p63 gene is a 
member of the p53 transcription . Expression of p63 is required for 
proper formation of epithelial tissues. Studies on the transcriptional 
control of specific genes involved in cell survival, proliferation, 
differentiation and adhesion have revealed the contributions of p63 to the 
continuously renewing stratified epithelium.  
 
Figure 9: Immunofluorescence analysis of 3D HSE 72 hours after UVA exposure: 
Ki67 signal(red)(a,f); dapi(blue)(g-n) and merge of Ki67-Dapi)(o-t). Scale bar 25µm; 
quantitative analysis of Ki67 on cells(u) at 6 and 72 hours after UVA exposure 
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In figure 9 is shown immunofluorescence analysis of Ki67; in details 
images (a-f) show ki67 signal; image(g-n) show dapi as nuclear staining 
and images (o-t) a merge of Ki67 and dapi. Quantitative investigations of 
immunofluorescence images (image 9-u) have found that Ki67 per cells 
in 3D HSE irradiated with UVA but not treated with sunscreen (UVA) 
decreased respectively 2.6 and 3.1 time compared to the control sample 
6 hours and  72 hours after UVA irradiation ( p<0.01); the decrease in 
Ki67 is avoided in the photoprotected samples(both topic&systemic and 
topic applications) that maintain the value of control; indeed no statistical 
difference is assessed between control sample and photoprotected ones, 
at both time points. Immunofluorescence of P63 marker is shown in 
image 10.  
 
Figure 10: Immunofluorescence analysis of HSE 72 hours after UVA exposure: 
K10(red) and DAPI(a,f); K10 and P63(green)(g-n). Scale bar 50µm; quantitative 
analysis of p63 on cells (o) at 6 and 72 hours after UVA exposure. 
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The images shows the merge of K10 (keratin 10, marker of suprabasal 
layer) and P63 (fig10 a-f) and the merge of K10 and P63 (fig 10 g-n) at 
72 hours after UVA exposure. 
Quantitative investigation of p63 (fig 10o) has shown that the action of 
the UVA irradiation tends to decrease the number of basal stem cells 
given from the decreases of p63 marker (p <0.01) both at 6h and 72 
hours of UVA exposure; instead of in the samples treated with 
photoprotectans, the expression of P63 on total cells is more similar to 
the control sample both topic and topic&sistemic application. 
Conclusion 
In the present chapter, human skin equivalent model have been realized 
based on endogenous ECM in dermal and epithelial compartment. After 
a first morphological characterization which showed that our in vitro 
model has characteristics similar to a native tissue, we validated it as in 
vitro testing platform for biactive molecules. In details, we studied UVA 
induced dermal and epithelial damage and the efficacy of 
photoprotecants in preserving the structure and composition of the 
tissue. We rated the photodamage provided by the UVA dose that 
allowed physiological survival of the model but assured the expression of 
specific UVA-induced alterations [23]. Exposure to UVA, in particular, 
induces extensive changes in both the composition and architecture of 
the ECM-rich dermis [24] and in the dermis-epidermis crosstalk. It has 
been established that UVA radiation, in epithelial layer, caused effects 
on keratinocytes decreasing expression of the proliferation marker Ki-67 
[25] and induced apoptotic pathway, proving that down-regulation of p63 
in response to UVA is important to epidermal apoptosis [26]. As regards 
the UVA damage on dermal compartment, it is well known that MMP 
have an important role in photoaging process [27,28]. In particular, 
MMP1 acts directly on collagen I. MMP9 acts as a non-specific 
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collagenase, once the collagen has been cleaved by MMP1 it is further 
broken by MMP9. According to literature we found a decrease of both 
Ki67 and P63 in the sample UVA-treated, both at 6 and 72 hours after 
UVA exposure, proving that epidermal keratinocytes undergo apoptosis 
in response to UVA irradiation and loss their stemness. Moreover, we 
found an increase of MMP1 and MMP9, and a decrease in the collagen 
type I and III in the UVA sample. These results were also confirmed by 
the texture analysis performed on SHG images with GLCM which have 
demonstrated the difference between the denser and fine structure ﬁbrils 
collagen matrix of control sample, and the loss of ﬁne structure and 
structural organization of UVA treated sample. Regarding the 
photoprotecants, we tested retinoic acid a lipophilic molecule well known 
for its anti-aging and anti-UVA effects [29], and Dolichos biflorus, a cell 
culture extract that has been recently demonstrated [14] to protect 
cellular components from photo-damages due to the presence of 
flavonoids and their derivatives in its composition. We have used two 
different application of these photoprotecans; only topical application (ie 
only on the epidermis layer) and both topical & systemic application 
(both in the dermis that in the epithelium). The choise of 2 routes of 
administration may be linked on speciﬁc penetration potential of 
photochemicals, or on epidermis barrier function and also on 
keratinocytes absorption metabolization process.  
In both applications, we found  a measurable improvement in tissue 
viability. In fact, the level ofKi67 and P63 are similar to not photoexposed 
sample proving their antioxidant activity on scavenging the free radicals 
minimizing the cellular damage. Furthermore, MMPs induction is blocked 
after UVA irradiation and, immature and mature collagen synthesis was 
preserved and maintained at the same value of the control both at 6 and 
72 hours after UVA irradiation. These results showed that the only 
topical application fails to protect the tissue ,in both dermal and epithelial 
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layer from UVA damage; demonstrating the importance of having an 
adequate dermis/epidermis crosstalk; and to have a dermis matrix which 
is not inert, but which is also remodels thanks to the stimuli it receives 
from the epidermis. In conclusion, the possibility to have an in vitro 
platform, such as uman skin model, to investigate the action of external 
stimuli such as UVA exposure, presents important consequence not only 
in dermatology but also in cosmetology science; it opens the possibility 
to investigate in vitro cosmetic function previously assessable only in 
vivo. Also we hypothesized that the human skin model realized could be 
used not only in vitro but also in vivo as skin substitute in clinical 
application. 
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